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This dissertation explores the combination of two emergent areas within contemporary biosensing, 
smartphone based spectroscopy and photonic crystal enhanced microscopy, and how these 
technologies can be combined to produce a fundamentally novel point-of-care testing paradigm: a 
portable device platform capable of non-amplifying, digital-detection for high-sensitivity 
diagnostics.  In this work, I describe the development of this system, moving from usage-specific 
benchtop and smartphone based devices demonstrating proof-of-concept capabilities, to a 
multimodal smartphone platform compatible with thousands of existing spectroscopic assays. The 
resulting smartphone biosensor can perform various clinically-relevant tests with physiologically-
relevant sensitivities.  Next, photonic crystal enhanced microscopy is described for uses in the 
micrometer and nanometer scales for use both to study cellular and subcellular behavior and also 
to perform single-particle attachment quantification. Finally, this work explores how the single-
particle attachment quantification capability can be leveraged to measure HIV viral load using a 
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CHAPTER 1: INTRODUCTION 
Since the introduction of smartphones in 2004, interest in coupling them with wearable 
devices for monitoring health-related metrics has grown to an over $15 billion/year market1 , 
focused mainly upon reporting physiological parameters such as heart rate and blood pressure.  
While the majority of these consumer products are not classified as medical devices, there is 
intense interest in coupling new sensors to mobile devices to transition additional health 
diagnostics, particularly in vitro diagnostic (IVD) tests on bodily fluids from the laboratory to the 
point-of-care (POC).  Tests that can be facilitated through test-specific cartridges that interface 
with a readout instrument 2,3 or paper-based assays that can be interpreted by visual inspection 
have obtained regulatory approval that facilitates their use in POC settings.4,5 
 As smartphones continue to include greater computational power and more sophisticated 
imaging sensors that complement their capabilities for wireless communication and internet 
connectivity, the interface between IVD testing and mobile devices offers a powerful new POC 
testing paradigm.  The output of nearly all of the most common laboratory-based diagnostic tests 
can be sensed using a smartphone with sensitivity that rivals that of conventional laboratory-based 
benchtop instruments.  Examples include smartphone-based microscopy,6,7 fluorimetry,8,9 Enzyme 
Linked Immunosorbent Assay (ELISA),10 Polymerase Chain Reaction (PCR),11 and lateral flow 
assays.12,13  The reader is directed to recent reviews on the topic of smartphone-based 
biosensing.14,15  It is evident that while laboratory-based assays and detection instruments provide 
high throughput and automation, enormous needs exist to provide diagnostic information to people 
who lack convenient access to a diagnostic test facility.   Additionally, in many urgent health 
situations, an immediate result is required for feedback to the physician and patient.   
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 Over the past six years, I have engaged in research developing POC diagnostic platforms 
across the entire design process: from ideation through demonstration of utility.  In this dissertation 
I will describe the progression of that work from early “benchtop” devices, demonstrating basic 
capabilities, through final prototypes of smartphone-based platforms capable of performing 
myriads of diagnostic tests which are otherwise typically dependent on a standard laboratory 
infrastructure.  Then, I will describe the development of a novel detection strategy for a significant 
global health need, a point-of-care HIV viral load test, which relies on the fundamentals of earlier 
work combined with cutting-edge biosensing research.  I hope that this document will track the 
progression of smartphone biosensing from a “catch-up” phase of replicating detection modalities 
already refined in a laboratory setting to a future where novel biosensing research is developed 
using smartphone-based platforms from the onset.   
 This dissertation will be composed of two principal parts: first, a description of various 
projects focusing on the translation of existing spectrometric measurement platforms and assays 
to various smartphone-based devices, and second, a description of a nascent biosensing technique, 
Photonic Crystal Enhanced Microscopy (PCEM) and its subsequent development directly to a 
POCT context for providing digital detection of HIV viral load, a significant global health need 
unserved by contemporary POCT strategies. 
In Chapters 2 and 3, I will describe our early work demonstrating the feasibility of using 
the rear-facing CMOS camera of a smartphone as the imaging sensor of a spectrometer, and the 
development of lightpaths to perform three broad classes of existing spectrometric assays: 
absorbance, fluorescence, and label-free assays.  For both the absorption and label-free modalities, 
biological proof-of-concept experiments were completed and will be described demonstrating the 
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ability of a smartphone-based spectrometric system to perform measurements of analytes at ranges 
comparable to standard benchtop devices.   
In Chapters 4 and 5, I will narrow-in on a single spectroscopic modality, and explore the 
opportunities for biosensing provided by photonic crystals in more detail.  Unlike absorption and 
fluorescence-based measurements, PC-based biosensors have properties that are inherently 
spatially-related.  Individual attachment events to the sensor surface will generate localized 
responses of peak wavelength shift and a decrease in reflection efficiency.  Where initial 
experiments utilizing PCs with smartphone-based biosensors lose one dimension of spatial data in 
exchange for the spectral data, using a line-scanning approach of illumination and light collection 
can reconstitute that additional spatial dimension, allowing for spatially-resolved spectral 
information.  First, I will discuss the micro-scale implications for biological attachment, which 
roughly correspond to cellular and sub-cellular attachment events.  The experiments I describe will 
demonstrate the first uses of the PCEM instrument to detect cellular attachment, detachment, and 
chemotaxis on a PC sensor-surface.  Next, I will discuss the nano-scale implications, as we push 
the limits of spatial resolution in pursuit of the resolution of single molecule-attachment events.  
This provides an opportunity to perform “digital-detection” of attachment events, which opens up 
a world of non-amplification-based low-LOD diagnostics.  In Chapter 5, I will present the natural 
advantages that a PCEM-based detection method presents for a future POC diagnostic for HIV 
viral load, and will discuss the progress that has been made toward developing such an instrument.  
To close, I will discuss the future strengths and weaknesses of the developed platform for 




CHAPTER 2: DEVELOPMENT OF USAGE-SPECIFIC 
SMARTPHONE SPECTROMETERS1 
2.1 Introduction 
This chapter aims to investigate two fundamental optical biosensing modalities: the 
absorption-based measurement of enzyme-linked immunosorbent assays (ELISAs) and the label-
free measurement of biomolecular adsorption on photonic crystal (PC) sensors.  First, an overview 
of ELISA testing will be given, followed by a survey of contemporary attempts to bring the 
technology out of the traditional laboratory setting.  Then, using the developed smartphone based 
biosensing platform, a demonstration of the system will be completed using a cancer biomarker, 
human interleukin 6 (IL-6), and a peanut allergen, Ara h 1.  Then, the underpinnings of photonic 
crystal-based detection will be discussed, followed by a summary of the practical experiments that 
have been demonstrated thus far on a smartphone-based platform.  The work in this chapter is 
meant to compliment other work that has been completed in the realms of microfluidics and sample 
collection.  As a mainstay of diagnostic medicine, spectroscopy poses an important measurement 
technique to be translated to a point-of-care device, and the work in this chapter serves as an 
introduction to the first step of realizing a portable instrument capable of replicating measurements 
of traditional laboratory benchtop analyzers, which will be further refined in Chapter 3. 
2.2 Design of a Smartphone Biosensor 
2.2.1 Instrument Design and Fabrication 
 The instrument cradle was designed to interface with an iPhone 4 (800 MHz ARM 
Cortex A8, Omnivison OV5653 5MP BSI CMOS sensor with f/2.4, 5 element lens; Apple 
                                                 
1 This Chapter contains work previously published as outlined in both the Acknowledgements and References.  
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Inc.) by using the onboard, rear-facing camera as a digital light detector.  A custom cradle 
fabricated from anodized aluminum was designed to align the necessary optics with the 
phone camera.16 This cradle allows for the precise alignment of the optical path with the 
aperture of the smartphone camera, while maintaining full utility of the screen, enabling 
the camera to function as a spectrometer. The main optical path is comprised of a square 
channel with two rubber bands along its length so that optical components can be moved 
along the optical axis, but will maintain proper centering and not move freely on their own.  
For these experiments, two configurations were used, one for solid-phase PC-based 
measurements and the other for liquid-phase immunoassays, as shown schematically in 
Figure 2.1. 
 For the solid-phase system, a broadband light source (150 W halogen fiber optic 
high intensity illuminator; Cole Parmer) is used to illuminate a 100-micron pinhole at the 
end of the channel.  Upon entry, light is collimated (focal length, f=75mm) and linearly 
polarized to align the electric field with the PC grating. At the PC surface, the characteristic 
narrowband reflection occurs, and the remaining transmitted light is focused to a line via a 
cylindrical lens (f=50 mm) through the smartphone aperture and onto the CMOS sensor.  
Between the cylindrical lens and the smartphone is a diffraction grating (1200 lines/mm), 
which disperses light in one direction generating a spectral dimension on the resulting 
captured image.   
 For the liquid-phase system, the same broadband light source is used to illuminate 
the sample cuvette.  Light that is not absorbed by the sample is collected by a 1 mm diameter 
optical fiber and relayed to a 0.1 mm diameter pinhole at the end of the optical channel.  
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Light that enters the optical channel is similarly collimated (f=75mm), focused to a line by 





Figure 2.1. Schematic Drawings of Smartphone Biosensing Attachments for A) Absorption measurements for 
ELISA analysis and B) for PC-based label-free detection of biomolecular attachment.  To align the first order 
diffraction pattern with the CMOS sensor of the smartphone, the optical path is at an angle of approximately 47º.  In 
both systems, the pinhole serves to optically isolate the internal optical path and to maximize spectral resolution, as 
the diffracted spectrum is convoluted with the apparent light source, just as a slit does on a traditional spectrometer. 




instrument.   
 In both cases, the wavelength components of the light are separated by the 
diffraction grating, which disperses the light onto the pixels of the camera.  Illumination 
from the lamp is observed in the resulting camera image as a bright, rainbow band 
appearing near the center of the screen on the smartphone.  Although the iPhone4 camera 
image sensor has a total of 5 megapixels (2592 x 1936), the spectrum band covers 
approximately 750 pixels in the dispersive direction and it is roughly 100 pixels wide. 
Assuming a focal length of the iPhone4 lens of 3.85 mm, the wavelength separation 
between adjacent pixels in the spectral direction will be 0.334 nm/pixel.  Due to the spectral 
responsivity of the Si-based sensor and internal infrared cutoff filters within the camera 
optics, the range of wavelengths which may be observed by the system extends from 
approximately 400 to 700 nm.   
2.2.2 Use of the Smartphone Instrument 
 Before introduction to the cradle, the iPhone was prepared by first locking the focus 
and exposure of the native camera application by focusing on a point sufficiently far away 
in a dark room or hallway to focus the camera at an infinite distance in a low-light setting. 
The phone was then placed in the cradle, and a broadband illumination source was turned 
on at the end of the optical path.  The phone was aligned using adjustment knobs to achieve 
an x-y positioning providing a centered image of a broadband spectrum on the smartphone 
display.  The broadband light source used allowed for the manual manipulation of intensity, 
which was adjusted to maximize the dynamic range of the sensor for each of the two 
modalities.  For every measurement step, five consecutive images were captured using the 
native iPhone camera application and averaged to account for variations arising from the 
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camera hardware and sensor noise.  Red and green laser pointers (λ = 656.26 nm and λ = 
532.10 nm, respectively) measured with a spectrometer (USB2000+; Ocean Optics) were 
imaged using the smartphone system to provide reference wavelengths for calibration of 
the pixel to wavelength conversion.  
2.2.3 Image Processing and Wavelength Calibration 
Post-processing scripts were written in Matlab to convert raw images into absorption 
spectra.  Once images are uploaded to a PC, auto-thresholding is performed to crop non-data pixels 
from analysis by removing pixels with zero intensity, which yields a reduction of the image to a ~ 
1100 x 100 block of pixels.  The intensity of pixels in the non-spectral direction is averaged to 
yield a one-dimensional vector representation of the spectra.  
For both label-based and label-free modalities the data of interest lies in the non-transmitted 
light: either the light absorbed by the liquid sample or the resonantly reflected resonant peak of the 
PC.  The non-uniformity of both the red, green, and blue (RGB) color filters and the broadband 
illumination source across the visible wavelengths requires a broadband response be defined 
(Figure 2.2).  For each assay run, a blank consisting of aqueous solution for liquid-phase or air for 
solid phase is measured.  The resulting RGB responses are recorded, and all other analyte samples 
are subtracted from the blanked RGB channels.  To adjust for differences in RGB channel 
intensity, each channel is individually normalized to unity to provide a near-uniform spectral 
response.   
Pixel values are converted to wavelength values using a linear approximation via known 
pixel indices calculated by illuminating the pinhole with red and green laser pointers of known 
wavelength.  The laser emission profiles are fit with a 4th order polynomial curve to determine the 
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precise pixel index of each laser, and are then used to calculate the pixel-to-wavelength conversion, 






















Figure 2.2. Background spectra and calibration lasers.  Nonuniform transmission is observed for the bright field 
light source when imaged by the iPhone because of the RGB filter responses.  While broadband transmission must be 
corrected for via normalization, laser peaks display a high similarity between the spectrometer and the smartphone 
setup.  Using the known wavelengths of these lasers, the rest of the spectrum is interpolated linearly. 
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2.3 Smartphone-based ELISA 
 Since its introduction 40 years ago, ELISA has become one of the most widely 
adaptable tools for biological assays, allowing for the rapid quantification of proteins and 
antibodies for diseases ranging from HIV to cancer, yielding over 40,000 new articles 
involving the technology annually.17   
 An ELISA test is completed by immobilizing primary antibodies that possess an 
affinity for a specific biomolecule of interest onto a surface (usually a 96-well microplate).  
Next, the biomolecule of interest is introduced to the sensor surface where it will be bound 
by the immobilized antibody.  A secondary antibody, also complimentary to the molecule 
of interest, is conjugated to an enzyme and introduced to the sensor surface after a thorough 
washing to remove unbound molecules of interest.  These secondary antibodies will only 
bind to successfully captured molecules of interest.  Finally, after another series of washes, 
a chromogen, or color-generating compound, is introduced.  The enzyme present on the 
secondary antibody cleaves a peptide on the chromogen, which causes it to undergo a shift 
in its absorption spectrum to the visible range.  After the optical absorptions of standards 
at known concentrations are used to obtain a calibration curve, the concentrations of an 





Figure 2.3. Schematic of an ELISA Procedure. On a biosensor, immobilized antibody binds to a molecule of 
interest, which is then targeted by a secondary antibody.  The enzyme bound to this antibody catalyzes a color change 
of the chromogen, yielding a visible color in the solution which can then be quantified via spectroscopy.  
11 
 
 Here we demonstrate the use of a smartphone to perform the readout and 
quantification of any ELISA assay and compare results with those obtained from a 
conventional laboratory ELISA microplate reader for two representative biomarkers.  First, 
we demonstrate smartphone-based detection of a clinical biomolecule used for human 
disease diagnostics, IL-6.  Second, we demonstrate detection of a peanut allergen, Ara h 1, 
in the context of a food safety application.  Together, these biomarkers illustrate both the 
immediate utility and broad applicability of smartphone-based ELISA.   
 While there have been successful demonstrations of simplifying liquid handling 
steps18-20 and both macro- and microfluidic sample collection techniques amenable to 
POCT,21-24 high quality spectroscopic instruments have yet to be developed for on-site 
analysis.  By providing a spectroscopic reader for ELISA tests that is integrated with a 
mobile communication device, this technology can be used with the myriad of existing, 
well-studied ELISA procedures that have been well characterized for wavelength-specific 
analysis.  Combined with approaches for microfluidic-based automation of sample 
preparation procedures, the detection instrument presented here opens up the possibility of 
transferring ELISA-type tests to other fields requiring point of care analysis, such as quality 
control validation and agricultural monitoring.  
 The Cunningham lab is not unique in identifying the potential impact that a POCT device 
capable of performing immunoassays might have.  POCT immunoassay have been around for 
many years, and are readily identifiable as part of everyday life.  The most basic and prevalent 
form of POCT ELISA procedures would likely be a standard pregnancy test for human chorionic 
gonadotropin (hCG).  These tests are completed on a paper membrane, and the colorimetric output 
is observed as a binary readout via visual comparison with a control band.  More advanced versions 
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of ELISA as POCT have been demonstrated for a variety of conditions including tuberculosis,25 
HIV,26 and Giardia infection.27  While positive/negative results are acceptable for some types of 
diagnostic situations, often quantitative characterization of the amount of biological analyte is 
important within a specified range.   
To this end, several different approaches have been taken. Paper-based microfluidic ELISA 
tests were demonstrated by the Whitesides group in 2004 that provide a quantitative measurement 
system based upon single-wavelength absorption.28  This set of experiments is widely credited as 
the birth of paper microfluidics, a growing area of research for low-cost diagnostics.  Aside from 
the custom-built illumination/sensor system used in that work, the most prevalent method for 
quantitative POCT ELISA measurement uses either a CMOS or CCD to directly image solutions, 
which has recently been shown to be successful on a smartphone platform.29-32 
Systems such as these use various RGB color image weighting techniques to analyze 
concentrations of biological molecules of interest and therefore do not provide the spectrometric 
data required to perform a wavelength-based ELISA test.   CMOS sensors, like those found in 
most smartphone devices, are wavelength-independent photon collectors that convert photons into 
RGB pixels via physical filters.  These filters are comprised of colored dyes that each have both 
their own spectral response33 and an additional infrared cutoff filter with a response that provides 
a sharp cutoff that can vary among batches of identical cameras by 10 nm.34  In such a system, 
light intensity and color are intrinsically intertwined as they both rely on the number of photons 
captured by the RGB pixels compared with the number captured by those adjacent to them. 
Spectrometers have been a cornerstone of modern analytical chemistry.  The Beckman DU 
Spectrophotometer surpassed its contemporaries in popularity rapidly upon its invention, due 
largely to its increased spectral resolution across the entire range of measured wavelengths.  They 
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present the standard laboratory tool for the measurement of a variety of experiments as they can 
provide wavelength-specific absorption information.  The peaks at which a substance absorbs light 
the most correspond to chemical bonds and interactions at the molecular level, and can be used to 
identify specific components of a mixture.  By dispersing the spectrum of absorbed light along one 
of the CMOS camera dimensions, we can decouple the wavelength from intensity and thereby 
determine the wavelength-specific absorbance of samples.  This enables the accurate analysis of 
ELISA tests in a way that is immune to polychromatic spectral absorption variation. 
2.3.1 Quantification of Absorption-Based Measurements 
 For the experiments in this section,10 as the entirety of chromogenic spectral data for 
3,3’,5,5’ trimethylbenzidine (TMB) tests is captured solely in the blue channel of the RGB data, 
red and green channels are omitted from further calculation for ELISA-based measurements.  To 
generate absorption spectra, converted vector forms of the data were subtracted from those of a 
blank comprised of deionized (DI) water, and normalized to the RGB response of the sensor when 
illuminated without sample or cuvette present in the optical path. 
 To best compare the smartphone measurement sensitivity with that of a 
commercially available microplate reader, absorption values at λ = 450 nm are interpolated 
from calibrated spectra.  In addition, recognizing the potential value of the full spectral data 
for each sample, we calculate the integrative absorption from 410 < λ < 500 nm (Figure 
2.4).  Finally, the ELISA microplate reader data is imported from the instrument, 
appropriately normalized with respect to the blank, and averaged across replicates.   
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 For each measurement method, the absorption as a function of concentration for the 
calibration standards is fit to a four-parameter logistic regression model based upon a 
sigmoidal response curve governed by  






𝐵 (Eq. 3.1) 
where A is the minimum asymptote, B is the Hill’s slope, C is the inflection point, and D 
is the maximum asymptote.  While Beer-Lambert relations are often used to characterize 
absorption-based measurements, this logistic model was selected both on the 
recommendations of the assay protocols and to account for sensor saturation effects and 
polychromaticity for integrative absorption measurements.35 Limits of detection are 

































Figure 2.4. Example of Wavelength-Normalized Spectra Generated from Camera Images with Peanut Allergen 
Ara h 1.  Five independent smartphone images were averaged, then normalized to a blank.  Using lasers of known 
wavelength, images were converted to wavelength-dependent spectral absorbances.  Five concentrations of peanut 
allergen Ara h 1 are present to illustrate the difference in absorption characteristics.  The dashed line at λ=450 nm 
represents the single wavelength at which conventional ELISA measurements are taken using a microplate reader. 
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2.3.2 Human Interleukin 6 Quantification 
 Human Interleukin-6 (IL-6) is an important cytokine involved in the signaling 
cascade for the pro-inflammatory activation of B-cells following T-cell activation due to 
an antigen-mediated immune response.  Elevated expression of IL-6 in serum samples has 
been demonstrated as an important indicator in conditions ranging from diabetes to 
postoperative surgical stress.36-38 Additionally, IL-6 has been shown to be a relevant cancer 
biomarker important for the tracking, classification, and prognosis of various cancers 
including breast, hepatic, prostate, and renal varieties.39-42 
 A commercially available ELISA kit was purchased (Invitrogen) for the 
quantification of human IL-6.  Lyophilized IL-6 was reconstituted in standard diluent 
buffer, and serially diluted to concentrations of 512, 128, 32, 8, 2, 0.5 and 0.125 pg/mL.  
Standards were added to pre-prepared wells with immobilized anti-IL-6 antibodies in 
replicate (n=6).  A blank well was incubated with only diluent buffer.  Biotinylated anti-
IL-6 antibody was added to each well, and the solutions were allowed to incubate, covered, 
for 2 hours at room temperature on an orbital shaker (100 rpm).  Solutions were removed, 
and the wells were rinsed (4x) with the provided wash solution, per assay instructions.  
Streptavidin-HRP solution was added to each well, and the plate was returned to the shaker 
for another 30 minutes.  Another wash step was completed as before, and 100 µL 
chromogen solution (TMB) was added to each well.  The plate was then incubated for 10 
minutes in the dark, before applying 100 µL of the provided stop solution.    
 Using a commercially available ELISA microplate reader (BioTek Synergy HT), the 
completed assay was measured for absorbance at 450 nm, and blanked against the control 
well.  Afterward, samples were individually transferred to polystyrene cuvettes that were 
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placed in a cuvette holder fixed permanently in the optical path to minimize variation due 
to geometric inconsistencies.  A cuvette filled with 200 µL deionized water was used to 
normalize the RGB intensity values during image post-processing.   
 After data processing, the captured images were converted to absorption spectra that 
show clear concentration dependence across a range of wavelengths from 400 to 550 nm.  
From these spectra, either single wavelength measurements, akin to a microplate reader, or 
integrative absorption measurements can be calculated.  After digital data analysis, IL-6 
concentrations were observed to follow a sigmoidal dose-response curve, as expected 
(Figure 2.5).  From the data collected, it can be observed that the smartphone-based 
absorption at 450 nm replicates the microplate reader measurements throughout the entire 
range of concentrations, validating our instrument as a portable, low-cost alternative to 
traditional benchtop apparatus.  The integrative absorption has the same characteristic 
shape, and has a comparable Limit of Detection (LOD) lower than the minimum assayed 
concentration of .25 pg/ml.  Validation of these techniques using the results from the 
traditional microplate reader via Bland-Altman analysis are discussed in Section 3.6. 
2.3.3 Peanut Allergy Detection 
 The Ara group of peanut proteins consist of those that elicit allergic responses.  
While the specific proteins that an individual might be allergic to might vary, between 70 
% and 90 % of individuals allergic to peanut  products produce an immune response to the 
proteins Ara h 1, Ara h 2, and Ara h 6, a homolog for Ara h 2.43  In the US, over 1% of the 
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population has a self-reported peanut allergy, and this rate seems to be increasing in 
children.44  While many precautions exist to assist those with severe allergies to avoid 
peanut-based products, there is an increasing trend in the number of peanut allergy-related 
hospitalizations each year.45  There is a high potential value in a portable smartphone-based 
test for peanut allergens present in food, but careful quantification is absolutely essential.  
To our knowledge, this work presents the first proof-of-concept of a portable peanut assay 
Microplate Reader Smartphone Absorption at 450 nm
Smartphone Integrative Absorption
Figure 2.5. Concentration Dependence of Human IL-6. Samples were measured by an ELISA microplate reader, 
and then transferred to cuvettes to be measured by the smartphone instrument.  Concentrations ranging from 0.25 
pg/mL to 125 pg/mL were measured (n=2) along with a 0 pg/mL control (n=3).  Calculations of the data collected by 
the smartphone were completed both at 450 nm, so as to be directly comparable to conventional ELISA data, and as 
the integrative absorption from 410 <λ< 500 nm.  Limits of detection were calculated as three standard deviations 
above the 0 concentration measurement average. 
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that is capable of measuring peanut at concentrations less than the smallest measured No 
Observed Adverse Effect Levels (NOAELs).   
 A commercially available ELISA kit was purchased (R-Biopharm) for the 
quantification of peanut allergens Ara h1.  Samples were taken from cookies purchased at 
two local bakeries, Insomnia Cookies and Schnuck’s Grocer, as well as from pre-packaged 
vanilla Oreo® cookies.  Samples were extracted per kit instructions: 1 gram of each cookie 
sample was ground and placed in a solution of extraction buffer diluted from the provided 
10x concentrate.  Extraction was completed at 60oC for 10 minutes, followed by a 10-
minute centrifugation at 2,500 g.  The supernatant was then incubated, along with calibrated 
concentrations of peanut solution, in 400 µL wells with immobilized anti-Ara h 1 antibodies 
in triplicate.  Enzyme conjugate, chromogen, and stop solutions were then added for 10 
minutes each, with a 3x wash step in between.  The entire process can be completed in 
under an hour.   
 The same preparation protocol developed for the IL-6 assay was again used for the 
Ara h 1 assay.  The spectra were normalized to a water-filled cuvette during post-
processing, and positioning was repeated.  Lasers were used to recalibrate, and samples 
were measured in a similar fashion.  After digital data analysis, standard Ara h 1 
concentrations were also observed to follow a sigmoidal dose-response curve (Figures 2.6, 
2.7).  The limits of detection for the reported peanut assays were between .09 and .56 ppm.  
Once again, comparative validation was completed with a microplate reader via Bland-
Altman analysis.  Samples from peanut-containing cookies were found to have absorbances 
over that of the maximally assayed standard concentration (20 ppm), and so could not be 
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quantitatively measured without further dilution.   While neither Insomnia nor Schnuck’s 
claimed that their sugar cookies were safe for consumption by people with severe peanut 
allergies, the sugar cookie from Schnuck’s did, in fact, have an absorbance less than the 
assayed limit of detection (Figure 2.8).  As expected, prepackaged sandwich crackers 
without a label indicating a risk of nut contamination tested below the assay LOD. 
  
Figure 2.6. Concentration Dependence of Ara h 1.  Samples were measured by an ELISA microplate reader, and 
then transferred to cuvettes to be measured by the smartphone instrument.  Concentrations ranging from 2.5 ppm to 
20 ppm were measured along with a 0 ppm control (n=3).  Calculations of the data collected by the smartphone were 
completed both at 450 nm, so as to be directly comparable to the output of the ELISA microplate reader data, and as 
the integrative absorption from 410 to 500 nm.  Limits of detection were calculated as three standard deviations above 
the 0 concentration measurement average.   
Smartphone Integrative Absorption





Microplate Reader Smartphone Absorption at 450 nm
 Figure 2.7. Second Experiment of the Concentration Dependence of Ara h 1. Samples were measured by a 
conventional microplate reader, and then transferred to cuvettes to be measure by the smartphone biosensor.  
Concentrations ranging from 2.5 ppm to 20 ppm (n=3) were measured along with a 0 pg/mL control (n=5).  
Calculations of the data collected by the smartphone biosensor were completed both at 450 nm, so as to be directly 
comparable to the output of a commercially available ELISA microplate reader data, and as the integrative absorption 
from 410 to 500 nm.  Limits of detection were calculated as three standard deviations above the 0 concentration 
measurement average.   
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2.3.4 Comparison of Smartphone Sensitivity and ELISA Microplate Reader 
 For each sample measured in the conventional microplate reader, a spectrum was 
generated from a series of 5 collected images.  Both the absorption at λ=450 nm and the 
integrative absorption from λ=410 to 500 nm were calculated.  All data points were fit with 
the same four-parameter logistic model described above.  From the data collected, the 
absorptive LOD from either sensing modality appear to be in rough concordance, whereas 
the LOD obtained using the integrative absorption method is consistently 2-3x lower (Table 
2.1) than that obtained by considering the absorption of only a single wavelength.  This 
suggests that by taking advantage of the full spectral profile of the absorption peak resulting 
from the chromogen, it is possible to achieve a higher sensitivity than that obtained by 
observing a single wavelength.  The availability of the full spectral absorption information 
Figure 2.8. Quantification of Ara h 1 in Cookie Samples from Two Local Bakeries. Sample cookies were collected 
and contained separately in plastic to avoid cross-contamination.  Samples were measured, ground, and proteins were 
extracted following manufacturer protocol.  Vanilla Oreo® samples (n=3) and Schnuck’s cookie samples (n=2) were 
assayed with data in Figure 5, and Insomnia cookies were assayed with data in Figure 6 (n=3).  As the cookies were 
run on two different assays, only the higher LOD is shown.   
* Peanut Butter cookies had concentrations of Ara h 1 higher than the maximum assayed standard concentration, so 
significant dilution would be required for accurate quantification. 
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also enables the system to easily function with a broad range of chromogens that generate 








Smartphone     
Integrative 
Absorption 
Experiment 1 0.314 ppm 0.268 ppm 0.107 ppm 
Experiment 2 0.529 ppm 0.560 ppm 0.269 ppm 
 
Table 2.1. Comparison of detection limits of the Ara h 1 ELISA microplate reader, smartphone absorption at 
λ=450nm, and smartphone integrative absorption 
 In the realm of clinical medicine, the appearance of agreement between 
measurement techniques is not sufficient to support the adoption of a new instrument.  In 
the field of diagnostics, understanding the agreement between the new device and the 
current gold-standard is both important and non-trivial.  Recognizing that even gold-
standard techniques have inherent measurement uncertainty; a simple correlation analysis 
will not accurately reflect the combined uncertainties.  To address this issue, Bland and 
Altman developed a methodology that has become widely accepted as a viable technique, 
based upon the average measurements of the two techniques and the absolute differences 
at those averages.46 
 As ELISA absorbance measurements often have a lognormal distribution, a 
variation on the standard method using the geometric mean and log difference was applied 
to all non-zero values for each assay (Figure 2.9).46-48 The log differences showed a 
dependence on the magnitude of the measurement, so a regressive approach was used to 
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model the relation so appropriate limits of agreement could be attained.49  The regression 
was modeled as  
  ?̂? = 𝑏0 + 𝑏1?̂? (Eq. 2.1) 
where ?̂? is the vector of the geometric means of the two measurement techniques, ?̂? is the 
vector of absolute log differences, and b0 and b1 are the intercept and slope, respectively.  
For all three experiments, this provided a viable fit for the data; however, it was still 
necessary to see if the dependence on measurement magnitude continues into the residuals 
which are given by  
  𝑟 = 𝑐0 + 𝑐1𝑥 (Eq. 2.2) 
where r is the vector of residuals, and c0 and c1 are the slope and intercept for the residual 
regression.  The R2 value for the IL-6 assay residuals was significant at .224, while the 
Figure 2.9. Validation of Smartphone Measurement Technique versus Microplate Reader via Bland-Altman 
Analysis.  The lognormal quality of ELISA absorbances dictated the use of the geometric mean vs. log difference 
plot shown.  All nonzero points are plotted, with the dashed line being the mean of the primary linear regression.  
Solid lines represent the 95% confidence limits of agreement, which contain all but one data point across the three 
separate experiments.   
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values for the two Ara h 1 experiments were between .02 and .06.  As the relationship 
between the residuals and magnitude of the measurement was found to be significant in at 
least one of the experiments, the model of the residuals was combined with the first model 
to provide the 95% limits of agreement.  Assuming that these residuals follow a normal 
distribution, the limits of agreement can be calculated by combining Equations 3.1 and 3.2 
as discussed by Altman:50 
  𝑎1̂, 𝑎2̂ = 𝑏0 + 𝑏1?̂?  ± √𝜋/2 ∗ (𝑐0 + 𝑐1?̂?) (Eq. 2.3) 
where a1 and a2 are the 95% limits of agreement.  Of all data points assayed, only one point 
was found to be outside the ±1.96 S. D. limits of agreement (solid lines).  These data 
demonstrate a high level of consistency between the conventional ELISA microplate reader 
and the smartphone-based spectroscopic absorbance measurements.   
2.3.5 Discussion 
 The diagnostic potential for biomarkers such as IL-6 is significant.  Tracking the 
post-operative serum levels of biomolecules to assess the chances of post-operative 
complications could potentially increase positive outcomes for those patients via early-
detection,38 and decrease required post-operative in-hospital recovery time.  While long-
term monitoring of biomarkers could likely provide valuable prognostic information, the 
associated load on hospitals and diagnostic laboratory facilities make any such testing at 
best expensive, and at worst, unrealistic.  Similarly, the measurement of cancer-related 
biomarkers might prove a useful tracking mechanism for potential relapse or metastatic 
risk.51  The development of a cheap yet reliable ELISA reader could facilitate the 
development of a broadly available test in clinic-type environments.   
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 In contrast with medical diagnostic assays, allergen detection provides a consumer-
based testing opportunity.  While existing microplate readers are prohibitively expensive 
for individuals and designed specifically for laboratory settings, a handheld smartphone 
attachment is naturally amenable to an in-home testing environment.  Though ELISA 
assays require multiple liquid-handling steps, there have already been several successful 
demonstrations of ELISA performed as a lab-on-a-chip technique that could be integrated 
into a low cost, disposable cartridge, readily read by an instrument such as the one described 
here.  While significant work has gone into simplifying both the sample collection process 
and the liquid handling steps used in a traditional ELISA test, there is still a need for an 
instrument that can replicate the accuracy and repeatability of a microplate reader in a point-
of-care system. 
 Current alternatives for assay readout are based on either visual inspection or non-
spectral image analysis, neither of which provide the spectral resolution of traditional 
microplate readers.  ELISA testing is dependent on this spectral resolution, as the 
chromogens that are being measured are characterized by non-uniform absorption spectra 
in the visible range. Non-spectral methods of color analysis are subject to the variations in 
intensity present across various wavelengths, usually binned into three RGB channels via 
a Bayer filter.  By diffracting the wavelength of transmitted light along one of the physical 
dimensions of the CMOS sensor, we are able to separate the intensity information of the 
absorbed light from its wavelength, thereby allowing for the wavelength-specific 
quantification of chromogenic absorption.  Furthermore, our technique is broadly 
applicable across all visible wavelengths of the spectrum, even in regions where RGB 
channels sometimes overlap, including both 450 and 492 nm, wavelengths where the 
26 
 
important ELISA chromogens TMB and OPD maximally absorb, and where RGB analysis 
cannot suffice.    
    While there is general consensus on the importance of minimizing peanut material 
in non-peanut-containing foods, surprisingly little work has been done to quantify the 
amount of peanut protein required to produce an allergic reaction in affected individuals.  
Literature review-based statistical modeling has produced a starting point for such efforts, 
but variations in testing modalities as well as an abundance of situations where NOAELs 
could not be determined due to observed allergic responses at the lowest assayed dosage 
have resulted in a large number of patient results being excluded.52,53  One of the most 
promising studies of existing data was collected from clinical records of patients being 
tested, rather than from specific patient-recruited studies, which yielded an eliciting dose 
in 5% of the population (ED5) of 4.2 mg peanut protein.
52  While there is uncertainty in 
some of the numbers prevalent in the literature, the overall range of subjective NOAELs 
reported (or estimated) is typically between .4 and 10 mg protein,52,54-56 with objective ED5 
have been estimated as low as 1.5 mg.57  For a reasonable maximal daily intake of 500g of 
food based upon a 2000-3000 calorie diet, this would translate to .8 and 3 ppm peanut 
protein for minimum reported NOAEL and ED5, respectively, which are higher than the 
LOD for each of the testing methodologies used.  Thus, we have successfully demonstrated 
a point-of-use testing modality that can plausibly be used to measure clinically relevant 
amounts of peanut.   
 While this set of experiments has focused upon the demonstration of a liquid-based 
color absorption assay in the context of an ELISA, the approach demonstrated here may be 
applied to any assay that results in the color change of a liquid.  Colorimetric tests are 
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relatively common due to their ability to be qualitatively measured via visual inspection.  
Such tests are commonly used in testing liquids for pH, chlorination, and contaminants 
ranging from metals to organic material.  While qualitative information is useful, 
spectroscopic analysis can provide quantitative information that is consistent across phone 
manufacturers and independent of operator or hardware-based differences, a significant 
improvement over both visually comparative methods and non-spectrally resolved imaging 
methods.  Broadly, this instrument can perform any such test, assuming the absorption 
spectra exists within the visible range of wavelengths. 
2.4 Label-free Biodetection using Photonic Crystal Sensors 
While spectroscopic biological assays such as ELISA can be used for the detection of many 
biological analytes, their widespread adoption into scenarios outside the laboratory is hindered by 
the complexity of the assay protocol which often involves multiple liquid handling steps and 
conjugated antibodies.58-61 Detection of an analyte via one of its intrinsic physical properties 
(dielectric permittivity, mass, conductivity, or Raman scattering spectrum – for example), called 
“label-free” detection,62-64 is preferable for assay simplicity in terms of the number of reagents 
required, washing steps needed, and assay time. 
 Of all the label-free detection approaches that have been demonstrated, those based upon 
optical phenomena have been commercially preferred due to a combination of high sensitivity, 
low sensor cost, detection system robustness, and high throughput capacity.  Adsorption of 
biomolecules, viral particles, bacteria, or cells onto the surface of an optical biosensor transducer 
results in a shift in the conditions of optimal optical coupling, which can be measured by 
illuminating the transducer surface and measuring a property of the reflected or transmitted light.  
Such a detection approach is robust, and has become economically advantageous due to the advent 
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of low cost light emitting diodes and semiconductor lasers.  Surface plasmon resonance (SPR) 
based biosensors65-69 and photonic crystal (PC) optical biosensors70-75 are capable of detecting 
broad classes of biological analytes using their intrinsic dielectric permittivity. Each approach has 
been demonstrated using both large laboratory instruments and miniaturized (shoebox-sized) 
systems. However, no prior label-free optical biosensor instrument has been fully integrated with 
a smartphone, using the onboard camera itself as the detection instrument.  
 Here, we demonstrate the use of a smartphone to detect shifts in the resonant wavelength 
of a PC-based label-free biosensor.  PC biosensors are amenable to readout by a smartphone, as 
they function as narrow bandwidth reflection filters that can be measured by illuminating them at 
normal incidence with collimated white light. The PC used in this dissertation was designed to 
produce a high efficiency resonant reflection at a wavelength in the visible spectrum (λ= 565 nm) 
in air. Adsorption of biomolecules on the PC surface results in a red-shift of the resonant peak. To 
enable the rear-facing smartphone camera to measure this resonant peak, we use a setup very 
similar to that used for absorption measurements. While the phone and the optical components are 
held in position, the PC sensor itself may be inserted and removed from a narrow slot within the 
cradle. Importantly, the system incorporates the ability to compare wavelength shifts from adjacent 
“active” and “reference” regions of the PC as a means for incorporating an accurate experimental 
control. To demonstrate operation of this sensor and detection system, we will analyse the 
concentration dependence of the Protein A-porcine IgG interaction.   
2.4.1 Background on Photonic Crystals 
Photonic crystals (PCs) comprise a broad class of optical structures that are composed of a 
subwavelength periodic modulation of refractive index.  While these modulations have been 
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demonstrated in two and three-dimensional structures, this dissertation, both here, and in Chapter 
5, will focus on specific applications of the simplest case: the 1-dimensional periodic grating. 
As described in previous publications,76,77 these gratings can be easily manufactured via 
nanoreplica molding in a UV-curable polymer on a disposable plastic substrate.  Upon curing, this 
then provides a grating structure of the desired height, width, and period over which subsequent 
depositions of specific thicknesses of dielectrics can be made.  For these experiments, SiO2 and 
TiO2 were used for low- and high-refractive index materials, respectively.   
When collimated light is incident on the grating structure, a portion of the light is diffracted 
by the high-refractive index TiO2 layer in a wavelength- and angle-dependent manner, according 
to the grating equation: 
 Λ(sin(𝜃𝑖) − sin(𝜃𝑑)) = 𝑛𝜆 (Eq. 2.4) 
where Λ is the grating period, 𝑛 is the diffraction order, 𝜆 is the wavelength of light, and 𝜃𝑖 and 𝜃𝑑 
are the incident and diffracted angles, respectively.  Much of the light passes through without 
diffraction (𝑛 = 0), but some of the light undergoes first-order diffraction, which at normal 
incidence conveniently simplifies to  
 sin(𝜃𝑑) = −
𝜆
Λ
 (Eq. 2.5). 
Periodic waveguides such as this have been shown to have a specific resonance condition where 
the first-order diffracted light propagates as a guided mode due to total internal reflection when  
 2𝑘3𝑑 + 2Φ1,2 + 2Φ2,3 = 2𝜋𝑚 (Eq. 2.6) 
where 𝑘3 = 2𝜋/𝜆  is the wavevector of the light perpendicular to the grating in the SiO2, 𝑑 is the 
thickness of the grating, m is the order of diffraction and Φ1,2 and Φ2,3 are the Fresnel coefficients 
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due to differences in refractive index between the waveguide (SiO2) and surrounding layers.
78 At 
each interface of the waveguide that the internally refracted light hits, a portion of the light is 
refracted back out of the grating.  Light that undergoes two instances of internal refraction before 
escaping the grating is angularly aligned with light that simply passed through the grating, but it 
has undergone a phase shift relative to its non-diffracted counterpart, resultant from the Fresnel 
coefficients of reflection and diffraction and the difference in path length, which is given by  
 Φ = 2𝑘3𝑑 + 2Φ1,2 + 2Φ2,3 + 𝜋 (Eq. 2.7) 
It is important to note that this path length difference results in the twice-reflected and non-
reflected light being exactly 𝜋 out of phase, yielding complete destructive interference.79  
Similarly, light that undergoes a single internal refraction before escaping the waveguide can be 
shown to completely constructively interfere, yielding effectively 100% reflection.   
 Assuming constant perpendicular illumination, the only factors that affect this resonant 
wavelength are the Fresnel coefficients, which are dependent on the relative refractive indices of 
the grating and waveguide layers.  As biomolecules attach to the exposed surface of the PC, the 
effective refractive index of the TiO2 is slowly increased in a quantifiable manner, which serves 
as the foundation for label-free quantification of biomolecular attachment (Figure 2.10).  The 
Cunningham group has utilized this technique for a variety of analytes, including pancreatic cancer 
cytotoxicity screenings,80 the presence of porcine rotavirus in biological samples,81 and HIV viral 
load.82 
2.4.2 PC Characteristics for Smartphone Biosensing 
 For these experiments, a one-dimensional grating structure was created on a disposable 
plastic substrate in UV-curable polymer via nanoreplica molding.  As depicted in Figure 10, the 
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PC grating period was 360 nm and the depth was 60 nm.  The polymer grating was subsequently 
over-coated with sputtered thin films of SiO2 (t = 200 nm, refractive index = 1.54) and TiO2 (t = 
60 nm, refractive index = 2.35).  After fabrication, the flexible plastic substrates were attached to 
standard 25 by 75 mm glass slides using double-sided, pressure-activated adhesive film. The 
grating dimensions and thin film thicknesses were designed to provide a 95% efficient narrowband 
reflectance with a central wavelength of λ = 565 nm and a resonance bandwidth (full width at half-
maximum: FWHM) of λ ~5 nm when the surface of the PC is dry. Adsorption of biochemical 
molecules onto the surface of the PC results in an increase of the effective refractive index of the 
high refractive index waveguide layer, yielding a positive shift in the peak wavelength value 








































Protein A Surface 
Chemistry
Figure 2.10. A. The nanopatterned PC biosensor surface is functionalized via PVA and glutaraldehyde surface 
chemistry to facilitate the capture of IgG molecules.    B. The associated PWV undergoes a red-shift when antibodies 
attach to the surface and increase the effective refractive index of the TiO2 layer. 
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transmission efficiency by the smartphone).70 The magnitude of this shift can be directly correlated 
to the quantity of IgG present on the PC surface.  
2.4.3 Measurement Protocol 
To perform a label-free biological assay, the PC is initially prepared by immobilizing a 
capture molecule (such as an antibody, aptamer, or single-strand DNA sequence) that selectively 
recognizes the analyte in a test sample. The sensor surface is further prepared with a “blocking” 
step that prevents nonspecific adsorption of other molecules. The PWV of the sensor is measured 
prior to the addition of the target analyte to establish a baseline reading. Exposure of the sensor to 
the test sample results in adsorption of the analyte on the PC, which is followed by rinsing/drying 
the sensor to remove unbound molecules. A second PWV measurement is then taken and the 
difference in PWV is recorded as the shift due to the adsorption. The basic approach outlined in 
this protocol can be augmented by the incorporation of positive and negative experimental 
controls, including the use of a “reference” sensor that is prepared with an unmatched capture 
molecule, but still exposed to the test sample. Although all measurements reported here were taken 
with the PC surface in a dry state, the system could be further modified via the incorporation of a 
static liquid chamber or flow cell with the PC, so that the PWV shifts can be monitored kinetically. 
2.4.4 PC-based Biodetection with a Smartphone 
To demonstrate the ability of the sensor and detection instrument to perform a biodetection 
assay in which a layer of immobilized capture molecule is able to selectively capture a specific 
biomolecule of interest, we captured porcine immunoglobulin G (IgG) using an immobilized layer 
of Protein A.  While not in the realm of the biotin-streptavidin interaction, Protein A/G-antibody 
reactions are some of the stronger interactions observed in physiological conditions. 
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 To begin, the PC sensor was functionalized with an aldehyde-based surface chemistry to 
facilitate the attachment of Protein A.  To prepare the surface for functionalization, the PC slide 
was thoroughly cleaned using an acetone/IPA/DI-H2O wash, and then functionalized with a 10% 
solution of polyvinylamine in water at 40o C for two hours. It was then washed 3x in ultrapure 
water, and incubated in a 25% solution of glutaraldehyde in water (Sigma Aldrich) for 4 hours at 
room temperature.  After a subsequent 3x wash in ultrapure water and drying of the sensor surface, 
the PWV from 14 distinct locations on the functionalized PC surface were recorded by the 
smartphone detection instrument to establish the baseline PWV upon which subsequent 
wavelength shifts caused by the attachment of capture and target molecules would be compared. 
 Next, a custom-made polydimethylsiloxane (PDMS) gasket was adhered to the PC sensor 
surface to form 14 separate assay wells (diameter = 6 mm) over the 14 measurement locations.  
Each well was incubated with 60 μL of 0.5 mg/mL Protein A in .01M phosphate buffered solution 
(PBS; pH= 7.4) for 20 minutes. After Protein A immobilization, the wells were washed with PBS, 
the gasket was removed, and the PC sensor was dried.  A second PWV reading was gathered from 
each location, in order to establish the PWV shift due solely to the attachment of the Protein A 
layer.  Figure 2.11A shows the initial PWV associated with each of the 14 wells on a single PC 
Figure 2.11. Concentration dependent PWV shift of porcine IgG antibody. A. Variation in slide functionalization 
versus Protein A deposition. B. Protein A was immobilized on two PC sensors to detect concentrations of porcine IgG 
antibody present in quantities between 1 nM and 5000 nM. N = 3 for assay wells; N = 2 for control wells. 
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sensor, and the PWV shift induced at each location by Protein A deposition, demonstrating the 
initial variability induced by the PC functionalization (average PWV = 561.99 nm, stdev = 0.464 
nm), and the PWV shift induced by the Protein A deposition process (average ΔPWV= 1.46 nm, 
stdev = 0.288 nm).  These results demonstrate that the surface chemistry for protein attachment 
used here introduces a greater degree of variability than the variability of the subsequently 
observed sensor measurements from the smartphone instrument.  
 Prior to the exposure of the PC sensor to the IgG analyte, the gasket was replaced, and the 
PC was rehydrated with 60 μL PBS in each well for 10 minutes.  After aspiration, 60 μL of porcine 
IgG solutions were added to each well at concentrations ranging from 4.25 nM to 3.4 μM (Figure 
11 B) and incubated for 10 minutes.  After a rinse with 0.01 M PBS to remove unbound antibody, 
the PC sensor was dried and measured using the smartphone to calculate the ΔPWV induced by 
IgG attachment.  Concentration-dependent PWV shifts were observed, with each IgG 
concentration being measured in triplicate. Intra-sensor variability is low (average stdev for 
triplicate measurements was 0.335 nm). The lowest IgG concentration tested (4.25 nM) was 
observable above the negative control (0 nM IgG), indicating the ability to clearly measure 
wavelength shifts of 0.16 nm above sensor-specific background noise on that sensor (data not 
shown) that is limited by assay-related variability, rather than by the wavelength shift resolution 
of the detection instrument.  Despite its compact size and simplicity, the detection instrument can 
detect the presence of analytes in the nM concentration range with a “direct” assay.  The limits of 
detection of the system can be reduced further through the use of a variety of tags, such as 





 For the practical utility of the apparatus, it is important for future versions of the 
smartphone biosensor to have the ability to use wet samples by allowing for the use of thicker 
cartridges comprised of 3D wells, as opposed to the current methodology of current limitation of 
working with planar slides.  The decision to take measurements of the PC surface in a dry state 
was dictated by the desire to measure sensors in as simple of a manner as possible, without the 
possibility for bulk refractive index effects, or the incorporation of fluid flow (with associated 
pumps and valves) into the instrument. Detection in a dry state also allows for the assay steps to 
be performed separately from the detection step in both time and physical location, which would 
be desirable for several of the real-world detection scenarios being considered at that time.  
Incorporation of a microfluidic channel into the sensor through the fabrication of a more 
sophisticated cartridge would enable liquid-based detection and the potential for measuring the 
kinetics of analyte binding without altering the fundamental measurement approach, but was not 
addressed as a part of this work. 
 The experiments used to characterize the smartphone detection instrument presented in this 
paper serve to demonstrate the feasibility of measuring PWV shifts from a PC biosensor, rather 
than focusing on the application of the system to complex test samples that contain many 
potentially interfering compounds.  To address this issue for such applications, it will be necessary 
to incorporate reference sensors that can serve as negative controls to the effects of nonspecific 
binding. Such methods, commonly reported in the biosensor literature, should include multiple 
types of negative controls. First, as shown in this chapter, a detection experiment should include a 
sensor that is prepared with the capture molecule, but that is exposed to buffer rather than to the 
test sample. Secondly, the experiment should also include a sensor that is prepared with a capture 
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molecule that does not recognize the analyte (such as an antibody for a nonrelated antigen), and 
exposed to the test sample.  The combination of these two experimental controls can determine the 
mass density of analyte molecules that are bound nonspecifically to the sensor surface from a 
complex media, while at the same time taking into account common mode error sources such as 
temperature variability or bulk refractive index variability. 
2.5 Conclusions 
 In this chapter, we have demonstrated two usage cases for a novel smartphone-based 
spectrometer: absorption measurements for use with standard ELISA procedures, and PWV 
measurements for use with photonic crystal based label-free assays. In the first part of this chapter 
I described the successful detection of human IL-6, an important cancer biomarker, and Ara h 1, 
one of the principle peanut proteins responsible for causing a reaction.  Limits of detection were 
found to be comparable to those from the standard microplate reader, and the high level of 
agreement between the two sensing methods was demonstrated via Bland-Altman analysis.  
Finally, cookies from two local bakeries were tested for cross-contamination with peanut 
ingredients, and the instrument was demonstrated as a practical tool for detecting clinically 
relevant concentrations of allergen.   
 In the latter half of the chapter, the instrument was modified to provide polarized light 
which could be used to illuminate a photonic crystal at its resonance condition, providing a 
narrowband reflection phenomenon that redshifts as biomolecular adsorption takes place on the 
PC surface.  As demonstration of its biological utility, the concentration dependence of the Protein 
A-IgG interaction was investigated.  Concentrations of less than 1 µg/mL were successfully 
quantified.   
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 Absorption measurements comprise a large portion of the canonical optical diagnostic 
methodologies.  PC-based techniques, while significantly further behind in commercial 
development, offer several key benefits, namely the simplification of assay protocol due to their 
label-free nature.  In between the two, though, sits an important body of work within the realm of 
optical biosensing that should be mentioned: fluorescence-based assays.  There are a handful of 
interesting and useful diagnostic tests that can be completed with the use of fluorescent reporter 
probes including Förster resonant energy transfer, fluorescent lifetime, molecular beacon, and 
fluorescent polarization assays.  This modality was integrated with our prototype system via 
augmentation with a few external pieces on an optical bench.  One of the principle requirements 
of any fluorescent assay is the orthogonal illumination of the sample to minimize noise due to the 
light source in the fluorescent signal.  With this modification, new types of assays were added to 
those demonstrated here, further expanding the capabilities that the instrument can provide in a 
point-of-care environment.   
While expanding capabilities is important, ease-of-use and simplicity of design are two of 
the most important attributes for a POCT device.  A single instrument that could be used without 
significant modification for absorbance, fluorescence, and PC-based measurements, would 
provide a great benefit for clinicians.  In addition to simplicity of use, it would decrease the costs 
associated with the testing increase portability.  In the next chapter, such a device will be described 





CHAPTER 3: DEVELOPMENT OF A CONSOLIDATED TRI-
ANALYZER FOR POINT-OF-CARE DIAGNOSTICS1 
3.1 Introduction 
 To date, reported examples of smartphone-based IVD detection instruments are only 
capable of carrying out a single type of analysis, and with a few exceptions9,86 are capable of very 
limited multiplexing of tests.  Many laboratory-based microplate readers function as a “multi-
mode” instruments. These systems can transition between spectrometric absorption analysis (as 
used in ELISA assays), fluorometric analysis (as used in molecular beacon assays, fluorescent 
polarization (FP) assays, and luminescence-based assays), and, in the case of one product 
(PerkinElmer EnSight) label-free optical biosensor assays.  The ability of a detection system to 
easily transition between these modalities is a desirable one, as it enables the user to purchase only 
one instrument, and to use a common liquid handling format and software interface across a variety 
of applications.  In the previous chapter, I demonstrated that optical paths designed with specific 
measurement modalities using the rear-facing CMOS sensor of a contemporary smartphone are 
capable of measuring biological analytes with comparable ranges and limits of detection to those 
of standard laboratory analyzers, and based upon those early experiments, I now seek to combine 
three of these application-specific devices into a more-universal point-of-care testing device. 
 In this chapter, I report, to my knowledge, the first example of a smartphone-connected 
detection instrument that can measure the output of three distinct spectral biosensing modalities 
using two separate yet complimentary light paths.87  The three modalities represent a large fraction 
of all commercially available IVD tests for which a liquid sample changes color, or in which a 
                                                 
1  This Chapter contains work previously published as outlined in both the Acknowledgements and References. 
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liquid sample generates light as a visible indicator of the test’s outcome. The system is capable of 
performing spectral analysis of:  
• Optical Transmission of light through a test sample at specific wavelength(s).This 
measurement modality is commonly used in ELISA assays, liquid phase plasmonic 
nanoparticle-based tests including surface plasmon resonance (SPR) and localized surface 
plasmon resonance (LSPR),88-90 latex (or other nanoparticle-based) agglutination tests 
(LAT),91 and transmissive surface-based SPR, LSPR, and photonic crystal (PC) based 
tests.16,81,90  ELISA tests are a mainstay of contemporary biosensing tests, with ready-to-
go kits available for thousands of different biological targets.    
• Reflectance spectroscopy of light against a resonant optical transducer, as used in 
reflective label-free optical biosensing techniques such as SPR, PC, or reflectometric 
interference spectroscopy (RIFS).  While these direct binding label-free approaches do not 
currently have commercially available assay kits associated with them, they have been 
applied to thousands of biological analytes due to their simplicity and speed.92 
• Intensity spectroscopy from photon-generating assays such as those based upon 
fluorescence, chemiluminescence, bioluminescence or quantum-dot (QD) emission.  A 
broad variety of biosensing assays have such a readout, including fluorescence or 
chemiluminescent immunoassays (FIA, CLIA), fluorescent polarization (FP), Forster 
resonance energy transfer (FRET) as well as several molecular diagnostics, including 
polymerase chain reaction (PCR) and related loop-mediated isothermal amplification 
(LAMP).   
 Together, we estimate that these modalities can perform the necessary spectral readouts of 
90-95% of commercial immunoassays,93,94 the exception being radioimmunoassays (RIAs).  In 
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particular, as traditional ELISAs are being replaced by FIAs and CLIAs,95 the ability to easily 
switch between measurement modalities makes this system capable of maintaining utility for a 
variety of applications, and a useful opportunity to potentially compare different tests for the same 
analyte on the same point-of-care device.   
The Spectral Transmission-Reflectance-Intensity (TRI)-Analyzer takes advantage of the 
fact that all three modalities share the requirement to measure changes in the spectrum of light that 
is either absorbed, reflected, or emitted during the course of each type of IVD test. Our approach 
allows the user to select from one of two light paths: illumination of the assay with either the 
internal white LED of the smartphone that is typically used for “flash” exposure photography, or 
instead with an inexpensive green laser diode.  Accurate spectral analysis is performed by 
collecting light from the assay into an optical fiber, whose distal end directs light through a 
diffraction grating into the smartphone’s rear-facing internal camera.  The optical components are 
arranged wholly within a 3D-printed plastic cradle, containing a slot through which an assay 
cartridge is inserted.   
For many clinically relevant assays, multiple samples, replicates, positive/negative 
controls, and/or standard calibration solutions are required.  Few smartphone-based sensing 
platforms have demonstrated this capability beyond taking pictures of multiple colored samples 
and performing RGB-based color processing.  By converting the smartphone camera into a 
spectrometer, we lose the spatial discrimination that would allow simultaneous measurement of 
multiple samples.  Instead, multiplexing is achieved using a cartridge comprised of a linear series 
of liquid compartments that slides through an opening in the back of the cradle.  By pairing this 
linear motion with the smartphone’s ability to capture video, the spatial dimension separating the 
liquid chambers in the cartridge can be reconstituted with video post-processing, allowing for the 
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rapid and user-friendly measurement of multiple samples with a single motion, similar to swiping 
the magnetic strip of a credit card across a magnetic read head.  
Each sensing modality utilizes a unique cartridge configuration with the same overall form 
factor.  Both Transmission and Reflection modalities rely on a bifurcated illumination-collection 
fiber optic assembly that allows light from the smartphone flash to pass through a transparent 
cartridge and reflect off a stationary mirror positioned within the cradle or interact with a PC 
biosensor that operates as a wavelength-selective resonant mirror at the cartridge’s back wall, 
which is coated in an opaque dye to prevent reflection by the stationary mirror.  The Intensity 
modality uses cartridges with a transparent bottom to allow for orthogonal fluorescent excitation 
of the sample chambers.  All three modalities then collect the reflected light via the collecting fiber 
of the bifurcated fiber assembly which is then transmitted to the rear-facing camera of the 
smartphone.   
Importantly, the detection approach enables the user to “swipe” the cartridge through the 
instrument while the smartphone records video at 60 frames/second, and software can identify the 
frames from the video that represent images gathered while the center of each chamber is aligned 
with the illumination/read head.  Thus, the user is freed from the necessity of performing accurate 
alignment of the cartridge’s liquid chambers within the instrument, and the cartridge can be read 
in a similar manner to the approach used for scanning a credit card past a magnetic stripe reader. 
Multiplexing in this fashion enables a single cartridge to contain experimental controls, replicates, 
and a series of active tests. 
In this chapter, I demonstrate the Spectral TRI-Analyzer first for representative tests that 
verify its capabilities to measure liquid absorption spectra, PC biosensor resonant reflection spectra 
and fluorescence spectra.  Then, using commercially available diagnostic assay kits for 
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colorimetric output (ELISA) and fluorescence output, we validate the instrument’s two light paths 
and demonstrate that the Spectral TRI-Analyzer provides equivalent limits of detection (LOD) for 
reading the same assay with a commercially available 96-well microplate reader.  While there exist 
many opportunities to optimize assays for use with the TRI-Analyzer system, the focus of this 
chapter is on the demonstration of ease of translation of the thousands of existing, readily 
adaptable, commercial assays on the market.  Diagnostic assay kits for the PC biosensor modality 
are not commercially available.   
We chose our assay application demonstrations to represent tests that have important 
implications for maternal and neonatal health in developing parts of the world where a POC test 
would have enormous value.  First, we perform an ELISA assay for detection of fetal fibronectin, 
a biomarker protein test for expectant mothers that is diagnostic for spontaneous pre-term birth.  
Next, we perform a fluorescence-based assay for phenylalanine, a biomarker used to diagnose 
phenylketonuria, a life-threatening but manageable genetic condition, in newborns. 
3.2 Optical Design and Fabrication  
An important design requirement for the TRI-Analyzer was to make the approach easily 
adaptable to any smartphone with a rear-facing camera and rear-facing flash LED through small 
mechanical adjustment to the cradle body, but without adjustment of the core optical components.  
Thus, we chose to use optical fibers to bring light from the LED to the test sample, and to bring 
light from the test sample to the camera. In principle, the core optical components of the system 
would be identical for any smartphone, with two simple changes: 1) the phone interface is modified 
to use the physical dimensions of the phone to align the sensing fiber with the rear-facing camera 
and 2) the illumination fiber would be routed to collect light from the smartphone flash.  As shown 
in Figure 3.1, the distal end of the “illumination” fiber (100 µm diameter, multimode) is placed 
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directly in front of the flash LED to direct white light through the test sample for the Transmission 
and Reflectance modalities.  The other “sensing” fiber (100 µm diameter, multimode) collects light 
transmitted through the test sample, reflected from the PC, or emitted by fluorophores at its 
proximal end and directs it toward the rear-facing smartphone camera, oriented at a 41.3-degree 
angle.  The light emerging from the sensing fiber is collimated by an aspheric lens (EFL = 19 mm) 
and then focused in the non-spectral dimension with a cylindrical lens (EFL = 9 mm) before 
passing through a 1200 lines/mm transmission diffraction grating (Edmund Optics 49-578) held 
within the cradle body directly over the opening of the rear-facing camera.  The light is focused to 
optimize use of the CMOS pixels in the non-spectral dimension allowing for increased sensitivity.  
Figure 3.1. Design of Spectral TRI-Analyzer. A) Schematic of internal layout for optical and electrical 
components.  A custom bifurcated fiber (100um core with d=1.8 mm glass capillary tube (proximal) and 2x d=1.25 
mm ceramic ferrules, Coastal Connections) was used to compact the light path into a handheld device.  Fiber is 
arranged to maximize bend radius, increasing long-term stability.  B) 3D CAD model was created, comprised of 5 
plastic parts printed via stereolithography.  Two halves of optical housing maintain lens alignment and optical 
chamber isolation.  All portions of cradle were designed to slide together and attach with M3x0.5 machine screws.  
C) Glass capillary tube with bifurcated fibers and metal nut used to align the fiber in the cradle. D) Image of final 
device in use with absorption cartridge. 
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The proximal ends of the sensing and illumination fibers are gathered together in a bifurcated 
configuration, so they are directly adjacent and held within a glass capillary tube that is mounted 
in a slot within the cradle body.  The optical fiber assembly is the only custom-made component 
of the system, due to the specific fiber length requirements (71 mm for the illumination fiber and 
137 mm for the sensing fiber) and ferrules on the distal ends.  Due to the accuracy of the 3D 
printing technology used to generate the cradle (FormLabs, Form 2 at 50 µm resolution), all optical 
components (lenses, reflection mirror, optical fiber assembly, and green LED) may be placed into 
their respective holding locations in correct optical alignment without further modification and 
minimal tuning of the system with set screws for each of the fiber terminations.  
For transmission and reflection modalities the smartphone flash serves as the light source.  
It is collected by one of the two distal ends of the bifurcated optical fiber, and expanded to a 
collimated beam with a plano-convex lens (Figure 3.2).  After passing through the sample 
chamber, either complete reflection (Transmission) or wavelength-selective reflection (Reflection) 
results in the signal passing through the sample once again and being focused on the image of the 
proximal end of the sensing fiber for Transmission or Reflection modalities, respectively.  The 
mirror is mounted and aligned inside the cradle, where it serves as the default reflection surface. 
For the Intensity modality, a 532 nm laser diode (10 mW, 3V), similar to those found in green 
laser pointers, is shone orthogonally to the main optical path of the instrument.  With the flash 
turned off, the collecting light path of the instrument is augmented with an additional lens which 
serves to focus the collection to a point close to the rear face of the cartridge.  This lens is inserted 
into the optical path by pressing a button on the exterior of the cradle, which slides the lens into 
the correct position.  The laser is focused within the test sample at the same point within the 
45 
 
cartridge at which the collection lens is also focused to provide for maximal fluorescence 
collection.96   
All optical components were optimized via non-sequential optical simulation (Zemax), 
with total optical efficiency prioritized for the Intensity modality’s optical configuration. The 3D-
printed cradle is comprised of two housing pieces held together with steel fasteners to robustly 
Figure 3.2. Two principal light paths and cartridges for each of the three modalities. A) Reflection (PC-only) 
and Transmission (absorption or PC) optical pathway.  Collimated light from the on-board smartphone flash is 
directed through the sample chamber.  For reflection-based PC measurements, a back-coated cartridge prevents 
transmitted light from being collected.  For transmission measurements, light is reflected by cradle mirror directed 
toward the collection fiber.  B) Fluorescence/Luminescence Intensity optical pathway.  A laser pointer diode is co-
focused to a point near the back-side of the cartridge where the collection fiber is similarly focused via addition of a 
single plano-convex lens into the optical path via a SLA-printed slider actuated from outside the cradle.  Additional 
cartridge wells/housing was removed for clarity in B). C) “Sandwich” style cartridge fabrication alternating plastic 
or glass substrates with double-sided-adhesive (DSA) showing how different backings facilitate different modalities.  
D) Transmission cartridge showing inlet/outlets and optically-isolated chambers. E) Dyed PC for label-free 
Reflection measurements. F) Close-up of Intensity cartridge demonstrating selectively-dyed cartridge body allowing 
for bottom-illumination with 532 nm laser diode. 
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maintain optical alignment. Holes were threaded with an M3 tap, and final clearances of moving 
parts were adjusted by hand to allow for smooth sliding before mounting and alignment with 
machine screws.  Optical alignment was completed first with the transmission/reflection light path, 
and then with the intensity light path, using a cartridge with rhodamine 590 chloride (Exciton) 
laser dye to visualize the optical paths. 
The laser diode is powered by a custom circuit providing a constant-current to the diode 
from three on-board AAA batteries, based on a LED flashlight control circuit (Texas Instruments).  
This circuit is soldered on a small protoboard, and attached to a switch accessible from the outside 
of the cradle (visible in Figure 3.1D).   
To interface with the cradle, custom cartridges were designed to facilitate introduction of 
samples to the light path.  While all based on the same fundamental construction, each modality 
requires slight modifications to the cartridge design (Figure 3.2 C-F).  The cartridge bodies for 
each modality are comprised of a laser-cut acrylic sheet.  This acrylic sheet provides the separation 
between chambers, and the overall structure for the cartridge, which can be modified to support 
different sample measurement cross-sectional areas, sample volumes, and chamber spacings.  For 
our experiments, we selected a chamber spacing that would allow for user-friendly sample 
manipulation with an 8-channel multipipette.  Laser-cut 50-µm thick double-sided adhesive (DSA) 
(3M, Optically Clear Adhesive 8212) is applied to both sides and a thin acrylic cover with laser-
cut access ports is adhered to the front of the cartridge, as shown in the cross section of Figure 
3.2C.  The back of the cartridge is comprised of glass (Transmission cartridges), acrylic film 
(Intensity cartridges), or PC-coated polycarbonate film (Reflection cartridges).  Depending on the 
modality, different portions of cartridges are dyed with opaque black dye (Dykem 81724) (Figure 
3.2E-F) to prevent optical communication between adjacent fluid compartments and to provide a 
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clear boundary between cartridges for automated sensing of the compartments as they pass the 
illumination/read head during video-based cartridge scanning.  To provide consistent positioning 
of the cartridge in the light path, a copper spring is attached to the collection-end of the cartridge 
chamber, so the cartridges are pressed firmly against one wall of the cradle’s slot.   
A custom Android app was developed to assist with data collection.  This app sets 
parameters, including exposure time and focal length, to constant values to provide for inter-assay 
consistency and to facilitate data collection.  After the assay of choice has been completed and is 
ready to be measured, the App allows the user to choose the number of samples, standards, and 
replicates before walking the user through collection steps for each liquid chamber and/or 
cartridge.   
Qualitative proofs-of-concept for each of the three modalities were completed with 
prepared test liquids in the cartridge chambers (Figure 3.3). To demonstrate Transmission 
measurements, we prepared a series of diluted yellow food dye (McCormick) to a range such that 
measurable optical absorption was observable on the system (~1:1000), and then performed serial 
dilutions to observe concentration-dependent absorbance (Figure 3.3A).  Note that, as the dye 
absorbed primarily wavelengths in the blue portion of the spectrum, the blue wavelengths are 
removed from the image as the dye concentration increases.  Difficulties in aligning the sample 
chamber with the optical path for low concentrations of yellow dye resulted in a high standard 
deviation, which was addressed with dyed cartridges as shown in Figure 3.2D (data not shown).  
To demonstrate the Reflection modality, we used a PC-integrated cartridge and introduced 
mixtures of 0%, 20%, 40%, 60%, and 80% ethanol (EtOH) in water to manipulate the bulk 
refractive index of the liquid in contact with the PC (Figure 3.3B).  Note that only a narrow band 
of wavelengths are efficiently reflected by the PC into the sensing fiber, representing a narrow 
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bright red band in the spectrum image gathered by the phone’s image sensor.  A single cartridge 
was filled with water, followed by the 5 ethanol concentrations to normalize for intra-sensor 
variation in starting resonance wavelength.  By taking the middle row of pixels from the raw 
images, we observed a clear relationship (R2 =.986) between the change in peak wavelength value 
(PWV) reflected from the PC with the addition of EtOH solutions and the refractive index of the 
liquid inside the fluid compartment, corresponding to a 114.0 nm/RIU bulk refractive index 
sensitivity.  Finally, to demonstrate the Intensity modality, we used the laser to excite the 
Figure 3.3. Qualitative proof-of-concept of 3 principal modalities. A) Transmission. Yellow food dye was diluted in 
water at concentrations ranging from 1:1,000 to 1: 64,000, a 64x concentration range.  Absorption was measured by 
subtracting sample transmission from that of water.  Observable absorption occurred in the blue region (400-500nm) 
of the spectrum. Inset raw images correspond to concentration of yellow dye of their outline. B) Reflection. 0-80% 
mixtures of ethanol in water were prepared and introduced into a PC-based cartridge, producing narrowband 
reflection in the 580 nm range.  Measurements of each cartridge chamber filled with water were subtracted from 
measurements of those chambers filled with ethanol solutions to produce ΔPWV shifts. Inset raw image corresponds 
to concentration of ethanol of its outline. A central line of pixels was used to produce spectra shown. C) Intensity. 
R6G dye was diluted in water and excited with the on-board laser diode. Inset raw images correspond to 
concentration of R6G of their outline. 
49 
 
fluorescent emission of rhodamine 590 chloride (R6G) (Exciton) within a cartridge configured for 
Intensity measurements.  The dye was diluted to concentrations between 10-6 and 10-7.5 g/mL, and 
resultant images were processed to generate fluorescence intensity spectra (Figure 3.3C).  Note 
that the green emission from R6G is clearly visible over the entire range of concentrations, the 
intensity is concentration dependent, and that, due to the orthogonal illumination, a minimal 
amount of light from the laser diode illumination source is present within the fluorescence 
emission spectra, even at low R6G concentrations. 
3.3 Validation of the Spectral TRI-Analyzer with Commercial Diagnostic Tests 
To demonstrate the capabilities of the system, we selected a representative assay for each 
light path with a common theme of IVD tests performed in the context of maternal and child health. 
Recognized as two of the eight Millennium Development Goals (MDGs) by the UN, maternal and 
child health has remained one of the primary foci of global health strategies.  As we transition 
from the MDGs to the recently released Sustainable Development Goals (SDGs), the WHO 
released a retrospective analysis of our successes and remaining challenges in the realm of health 
around the world. From that report, most of the major successes coming out of the health related 
MDG efforts have been related to infectious diseases, while most of the largest shortfalls are within 
the realm of maternal and child health.  Many countries have initiated subsidized maternal and 
child health programs, and health outcomes have improved; however, there is significant work to 
be done to improve outcomes for mothers and children alike, which motivates the specific 
applications we have selected to demonstrate in this chapter.97,98    
3.3.1 Transmission/Reflection Light Path:  Fetal Fibronectin ELISA Assay 
According to the WHO, over 10% of babies born each year are preterm, and complications 
arising from these births constitute the single leading cause of death in children under the age of 
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5.99 While multiple strategies exist to reduce complications associated with preterm births, 
diagnosis can often be challenging.100  Fetal fibronectin is a glycoprotein that has a high negative 
predictive value for spontaneous preterm birth.101,102 Particularly when combined with a physical 
measurement of the cervical length, fetal fibronectin is an important diagnostic indicator to 
facilitate treatment, continued monitoring, or hospital referral of at-risk mothers. While rapid 
lateral flow-based assays exist, they are not quantitative, and require specialized proprietary 
readers.103,104  Serological detection of fFN is routine in a laboratory setting, and the translation of 
a fFN test to a point-of-care diagnostic would provide useful information to health care providers, 
particularly with populations at-risk for pre-term births.  
For fFN detection, a commercially available ELISA kit was purchased (CUSABIO) and 
used to generate standard curves, as well as measure spiked serum concentrations within 
physiologically relevant ranges.  Kit reagents were prepared following manufacturer instructions, 
and reactions were completed in the included 96-well microplate.  Standard concentrations were 
serially diluted and run in triplicate at concentrations ranging from 4 to 1000 ng/mL.  Spiked 
plasma samples were created at a concentration of 50 ng/mL from human plasma (n=3).  All 
samples were added to the microplate, and ELISA steps were completed per manufacturer 
directions.  After the addition of stop solution, the samples were immediately read in a benchtop 
Figure 3.4. Spectrum Processing. A) Boundary of the red channel is found in every row of the image and a circle 
is fit (B). C) Straightened spectral image used to generate a single data spectrum.  D) Laser pointers are used to 
determine pixel-to-wavelength conversion as reported previously. 
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96-well plate reader (BioTek, Synergy HT), and then transferred to a sample cartridge with a 
multichannel pipette.  
Filled cartridges were measured using the developed App to take five images of each 
sample as it was slid through the cartridge slot.  The cylindrical lens that extends the non-spectral 
dimension of spectra onto the image sensor introduces spherical aberration, resulting in a curved 
appearance of the resultant spectrum images, as shown in Figure 3.4A-B.  As this is a function of 
internal optics and not the alignment of the smartphone and the cradle, the curvature observed is 
constant throughout multiple measurements and multiple phone removals/insertions (data not 
shown). By fitting the pixel locations of where the red filter drops off (~580 nm) in each spectral 
row to a circular arc, spectra can be linearized and then summed in the non-spectral dimension 
(Figure 3.4C).  The result is a spectrum where pixel distance corresponds directly to wavelength, 
a relationship that can be interpolated from measuring two known lasers with the smartphone 
system and interpolating the wavelengths in between (Figure 3.4C).  Finally, to adjust for overall 
intensity variation resulting from imperfect cartridge alignment with the optical path, a linear 
scaling least-squares fit was performed on the spectrum above 500 nm (outside the region of 
interest of our chromogen absorbance) when compared to a broadband spectrum (measured with 
ultrapure water).  Resultant normalized transmission spectra were subtracted from the same 
broadband spectrum, resulting in absorption spectra (Figure 3.5).  Similar limits of detection were 
observed between the 96-well microplate reader and Spectral TRI-Analyzer, both well under the 
minimum assay detection range (25 ng/mL), with the lowest discernable assayed concentration 
being 37.0 and 12.3 ng/mL, respectively.  Bland-Altman analysis was performed on the 
measurements from the 96-well plate reader and the Spectral TRI-Analyzer, and all data were 




3.3.2 Intensity Light Path: Phenylalanine Fluorescent Assay 
The prevention of phenylketonuria-associated mental deficits been recognized at one of the 
largest public health successes of the past 50 years with over 4000 lives saved since screening 
methods began in the US 50 years ago.105  Global prevalence is regionally varied, ranging from 
1/200,000 in Finland to 1/2,600 in Turkey.106  Traditional newborn screening techniques are based 
on a heel prick, originally used for bacterial metabolic assay, but now often run via mass 
spectroscopy.107-109    Benefits of translating newborn birth screening tests to a smartphone-based 
Figure 3.5. A) and B) Sample transmission spectra, absorption spectra, and raw RGB image data (insets) for 4 and 
110 ng/mL samples of fFN, respectively.  C) and D) Comparative dose-response curves for spectral TRI-analyzer 
and 96-well microplate reader.  Standard concentrations from 4 to 1000 ng/mL were assayed along with a human 
serum sample spiked at 50 ng/mL (not shown).  Limit of detection was determined as 3 standard deviations over the 




point-of-care device including cloud-
integration and data storage, familiarity of 
user-interface, cost-effectiveness and 
portability, directly map to challenges 
identified by the US Department of Health 
and Human Services, including the 
feasibility of statewide surveillance, 
tracking, and reporting, the roles and 
responsibilities of a broad and varied user 
base, and the cost and number of tests 
needed.110 
A commercially available assay kit was purchased (Sigma Aldrich) for the quantification 
of human phenylalanine.  The phenylalanine standard was reconstituted in water, and serially 
diluted to concentrations of 0.8, .6, 0.4, 0.2, 0.1, 0.05, and 0 nmol/well.  Human serum samples 
were deproteinized using a 10kDa MWCO spin filter before being diluted with assay buffer and 
added to wells in triplicate (n = 3).  The samples were pre-treated for 10 minutes at room 
temperature with tyrosinase to control for background interference.  A sample/standard reaction 
mixture of developer, enzyme mix, and buffer was added to each of the wells per manufacturer 
directions.  The solutions were allowed to incubate, covered and protected from light, for 20 
minutes at 37 C.  Using a commercially available 96-well microplate reader (BioTek, Synergy 
HT), the completed assay was measured for fluorescence, exciting at λ=535 nm and measuring at 
λ =587 nm.  Samples were then transferred to cartridges, as described previously, and measured 
























Figure 3.6. Bland-Altman Analysis of Spectral TRI-
Analyzer compared with standard microplate reader for 
readout of fFN assay.  A variation on the standard Bland-
Altman method using the geometric mean and log difference 
was applied to all non-zero values for each assay (Bland).  
The log differences showed a dependence on the magnitude 
of the measurement, so a regressive approach was used to 
model the relation, as described by Bland (mean of regression 
shown with dashed line). ±1.96 S.D. limits of agreement are 




For data acquisition of the fluorescence 
data, an improved data collection procedure 
was developed.  For absorption-based 
measurements, the stability of light output is 
time insensitive; however, with fluorescent 
dyes, both excitation intensity variation 
resulting from commercial laser diodes (even 
after circuit-based feedback control) and 
fluorophore photobleaching result in a time-
dependence of our measurements.  To mitigate 
these variances, we developed a post-
processing method that allows us to capture 
data as a video as the user slides the cartridge through the cradle, thereby reconstituting the spatial 
dimension in which the multiple sample chambers are introduced into the light path.  By analyzing 
mean pixel value across each frame of the video, contiguous framesets of signal corresponding to 
each of the sample chambers in the cartridge could be identified (Figure 3.7).  The center 80% of 
these frames were averaged, and used as an image to generate a spectrum, as done with the ELISA 
data.  These spectra were then normalized using the measured integrated area of the excitation 
laser of the sample chambers before assay completion.  This normalization method was validated 
using Bland-Altman Analysis (Figure 3.8).  The resultant fluorescence spectra resulted in a clear 
dose-response curve with a comparable limit of detection to that of the commercially available 
plate reader (Figure 3.9).  The limit of detection for the Spectral TRI-Analyzer was less than the 
lowest assayed concentration (0.5 nmol), while the limit of detection for the 96-well plate reader 
Figure 3.7. Video Processing and Normalization. A) 
Average pixel intensity of a data-collection video 
showing clear demarcation of 8 sample wells.  B and C) 
Example fluorescent spectrum showing regions used to 
normalize the data. 
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was between 0.5 nmol and 1.0 nmol.  We 
observe saturation of our signal at higher 
analyte concentrations, suggesting our 
system may have a lower dynamic range 
than the microplate reader. 
3.4 Conclusions 
Our unique Spectral TRI-Analyzer 
system demonstrates the breadth of IVD 
assay possibilities and applications that can 
be achieved within a single instrument.  
Each of the three optical biosensing 
modalities offers up a wide array of existing assays that have been developed for the laboratory 
setting that can be rapidly translated to be used with such a POCT device.   
The development of this device takes advantage of both the rapid improvements to 
smartphone hardware and software as well as the significant improvements in resolution and 
affordability of SLA-based 3D printing.  
Over the past ten years the rise of low-cost, consumer-grade 3D printers has resulted in the 
“maker community” developing into a 5.1-billion-dollar industry. The first wave of consumer 
products was comprised of FDM-based additive technology due to its ease of use, lack of mess, 
and minimal danger. SLA, by comparison, has remained largely in the industrial/research realm, 
though continued improvements in technology suggest that it could find a home in the consumer 
marketplace. Now capable of achieving 10-100 µm resolution, consumer grade SLA-based 




















Figure 3.8. Bland-Altman Analysis of Spectral TRI-Analyzer 
compared with standard microplate reader for readout of 
phenylalanine assay.  A variation on the standard Bland-
Altman method using the geometric mean and log difference 
was applied to all non-zero values for each assay.  The log 
differences showed a dependence on the magnitude of the 
measurement, so a regressive approach was used to model the 
relation, as described by Bland (mean of regression shown 
with dashed line). One point was found to be outside the 
±1.96 S.D. limits of agreement (solid lines).   
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Together, the disruptive technologies of smartphones and 3D printing pose a unique 
opportunity for the rapid development of low-cost point-of-use biosensing devices. Traditional 
optical alignment requires significant amounts of expensive hardware and bulky interfacing 
equipment to position lenses and other components in custom alignments. 3D printing presents a 
unique benefit in being able to rapidly produce custom mounts and interfaces. By coupling these 
two technologies together, we have demonstrated an exciting frontier of rapid-prototyped, low-
cost, smartphone-based optical devices for use at the point of care. Additional TRI-Analyzers have 
been made quickly and cheaply for distribution to collaborators in a way that benchtop-based 
proof-of-concept optical systems simply cannot.96 
This demonstration paves the way for a variety of prototyping applications in optical 
system design where 3D-printed optical mounts could augment or even replace conventional 
benchtop optical assembly and alignment.  In particular, within the realm of optical biosensors 
designed for the point-of-care, this presents significant potential to create new optical systems that 
can proceed from computer simulation directly to handheld prototype. 
Similarly, we have demonstrated a rapid-prototype-friendly method for micro- and milli-
fluidic cartridges for use with mobile biosensing devices.  By linearizing fluid chambers into multi-
sample cartridges, we can provide simple multiplexing which is useful both for assays requiring 
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multiple standards or controls, or situations where many samples might be run at once.  The 
simplicity of our laser-cut acrylic sheet and DSA assembly opens the door for a myriad of other 
possible cartridge configurations, including increasing the number of sample chambers per 
cartridge for further multiplexing, or incorporating other microfluidic assay steps such as sample 
lysis, mixing, or other mainstays of microfluidic-chip based technology.  For example, the specific 
dimensions and layout of our cartridges was designed to maximize convenience for interfacing 
between the assay solutions run on our benchtop comparison instruments that used a 96-well plate 
format by having sample ports spaced and sized to match the end of an 8-well multichannel pipette. 
Figure 3.9. Results of Phenylketonuria Assay.  A) and B) Sample transmission spectra, absorption spectra, and raw 
RGB image data (insets) for .8 and .2 nmol samples of phenylalanine, respectively.  C) and D) Comparative dose-
response curves for spectral TRI-analyzer and 96-well microplate reader.  Standard concentrations from 0 to 8 nmol 





In the demonstration of our system with existing commercial assays we sought to 
exemplify the sorts of laboratory-grade tests that could be directly transferred to the point-of-care.  
Thousands of these kits exist that rely on optical readout of sandwich immunoassays with either 
absorbance or fluorescence-based reporting molecules (ELISA, FIA, CLIA), and many new assays 
are being developed based upon other novel techniques, including those using bioluminescence, 
SPR, PCs or other selective-resonance phenomena.   
Video-based capture of sample signals is a natural complement to our developed linear 
cartridge, further simplifying multi-analyte multiplexing into a more user-friendly interface.  This 
represents a novel data collection method that represents yet another natural benefit of harnessing 
extant smartphone imaging technology for spectral analysis and biosensing applications.  To our 
knowledge, no such video-based multiplexing of spectral data has been described. The developed 
image processing holds potential for further expansion into future devices that can take advantage 
of such a ‘swipe’ based interface.  The swiping of a credit card is a ubiquitous motion that readily 
simplifies multiplexed sample measurements compared to those in a typical cuvette-based 
measurement system.   
The presented results of both proof-of-concept assays demonstrate that the Spectral TRI-
Analyzer can replicate the sensitivity of conventional benchtop laboratory instruments.  In both 
assays, our smartphone-based system could detect concentrations of assayed analyte less than 
those detected on a conventional laboratory instrument.  The single largest compromise observed 
with our system was a decrease in dynamic range for the assays.  In the fFN experiment, near-
complete absorption of light at 450 nm at high concentrations resulted in signal saturation.  For 
this particular assay, this would likely be acceptable as threshold ranges from literature range from 
10-200 ng/mL111-113.  Similarly, in the phenylalanine assay, our instrument did not produce a linear 
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dose-response curve, instead demonstrating a saturation-curve relationship at higher 
concentrations.  Likely using a 4-parameter logistic growth curve instead of a linear fit would 
allow for appropriate unknown concentrations to be determined using our system, but as shown 
by our Bland-Altman analysis for this data, even the unknown concentration in our serum sample 
was shown to be measured with agreement between it and our benchtop analyzer.  This level of 
agreement was demonstrated for both assays at all concentrations, suggesting that our device can 
successfully reproduce the expected assay measurements from identical samples. 
  A key challenge in developing any successful IVD for use at the point-of-care is achieving 
a device that is financially feasible.  To construct a single system, the cost of components of our 
system was approximately $550.  Many previous proof-of-concept demonstrations have focused 
on a single usage case, which significantly decreases the cost effectiveness of any diagnostic 
device.  The broad applicability of our device provides a necessary linkage between early proof-
of-concept work (Chapter 2) and the future possibility of truly portable POC devices being 
developed at the frontiers of bioengineering (as the one described in Chapter 5).  Demonstrated 
here is just one example set of related tests that individually might not result in a commercially 
viable IVD device, but together, provide a powerful opportunity to distribute maternal and child 
health monitoring from central laboratories to clinics and health outposts worldwide.  These 
experiments represent the end of the academic engineering process, with a successful translation 
arrangement with a corporate partner who will continue to commercialize the underlying 
technology for applications in both human and animal health arenas.  In the next half of this 
dissertation, I will present a new iteration of the engineering design process. This time, instead of 
translating mature laboratory instruments to the POCT paradigm, I hope to inject point-of-care 
considerations into the initial phases of cutting edge of biosensor development.  
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CHAPTER 4: HIGH-SENSITIVITY BIODETECTION: PHOTONIC 
CRYSTAL ENHANCED MICROSCOPY1 
4.1 Introduction  
As discussed in Section 2.4, photonic crystals present a unique biosensing opportunity to 
observe attachment-based events without the use of labels, dyes, or amplification.  In Chapters 2 
and 3, we discuss the bulk properties of PC biosensing, where many individual attachment events 
affect the PC resonance condition of a region-of-interest on the PC sensor.  When using the 
imaging sensor of a smartphone as previously described, we convert one of the dimensions of the 
imaging sensor to a spectral dimension, which results in the loss of one dimension of spectral 
information.  This means that the resultant PWV images represent the average PWV shift of the 
entire illuminated area.  In the pursuit of high-sensitivity, low-concentration detection of 
biomolecular interactions, it is possible to alter this illumination area to a narrow line, which can 
then be scanned across a surface, thereby allowing us to reintroduce the second spatial dimension 
previously sacrificed.  This third dimension is generated by moving a PC sensor incrementally and 
taking serial images, which can then be reconstituted.  The spatial resolution afforded by this 
change results in a device (termed the Photonic Crystal Enhanced Microscope, or PCEM)114 that 
can move from millimeter-scale ROI analysis to micrometer-scale resolution of biological 
attachment events, making it a unique tool for label-free detection of cellular processes, as will be 
discussed in this chapter.  Then, in Chapter 5, we will investigate the limits of spatial resolution 
for the PCEM, demonstrating nanometer-scale individual attachment events, providing a unique 
opportunity for digital detection of protein and other subcellular interactions.  That work will 
                                                 
1   This Chapter contains work previously published as outlined in both the Acknowledgements and References. 
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enable the development of a similarly spatially-resolved smartphone-based instrument for point-
of-care applications.  To explore the micrometer-scale capabilities of the PCEM, we will look at 
cell-surface interactions and how they change over time in vivo, taking advantage of the truly label-
free capabilities of the instrument. 
Cell membrane interactions with surfaces are fundamental aspects of many in vivo 
biological phenomena including differentiation, growth, apoptosis, tumor metastasis and injury 
response115,116. Characterizing these processes in the laboratory traditionally involves fluorescent 
dyes, fluorescent proteins, histological stains, or fixation. Such approaches are either cytotoxic, or 
temporally constrained by the effects of fluorescence photobleaching. While these techniques 
elucidate the mechanics and outcomes of cellular processes, the lack of long-term, time-course 
data collection poses a serious compromise to the study of natural cell behavior during processes 
that occur over extended time scales like cell invasion117 and chemotaxis118. 
 In order to address the challenges inherent in label-based cell imaging techniques, label-
free microscopy technologies have been demonstrated as effective tools for measuring an 
increasingly diverse range of cellular processes119-122. Label-free microscopy involves a biosensor 
transducer surface that generates an electrical or optical signal when cells interact with it. 
Biosensors measure intrinsic cellular properties (such as dielectric permittivity) that can be used 
to determine the number of cells in contact with the transducer, or to determine the distribution of 
focal adhesion points. Such transducers may be prepared with surface coatings that either 
selectively capture specific cell populations through interaction with proteins expressed on their 
outer membranes or mimic the in vivo microenvironment within tissues. 
 Due to the fundamental importance of cell-surface interactions, several technologies have 
sought to quantify and image cell membrane adhesion. Surface Plasmon Resonance imaging 
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(SPRi)123 is capable of detecting cell attachment to a gold surface by measuring changes in the 
intensity of front-reflected light at a fixed angle and wavelength, but practical limitations degrade 
image quality. SPRi requires illumination to pass through cell structures, which introduces changes 
in reflected light intensity that are not related to cell surface attachment, and the lateral propagation 
distance of surface plasmons limits spatial resolution124. Interpretation of SPRi images is 
complicated by the variability of reflected light intensity introduced by scattering, inhomogeneity 
of the light source, and nonuniformity of the sensor surface125, while non-normal light via prism 
coupling hinders the quality of focus126. Atomic force microscopy (AFM)127 has been used to study 
surface morphology and mechanical properties of cells by using a probe tip to collect localized 
force response. While it provides information about biological surfaces by making measurements 
from above, AFM does not analyse the interaction between cells and their substrates. In addition, 
as a probe scanning approach, the throughput of AFM is limited, enabling the study of only a small 
number of cells at once.  
 In this chapter, we demonstrate photonic crystal enhanced microscopy (PCEM) as a label-
free biosensor-based cell attachment imaging approach that quantifies cell-surface interactions 
with spatial resolution sufficient for monitoring intra-cell attachment distribution, and temporal 
resolution sufficient for generating time-lapse movies during processes that include chemotaxis, 
apoptosis, differentiation, and division. Critically, these studies can be performed on extracellular 
matrix (ECM) protein functionalized substrates, retaining the capacity to define the chemistry of 
cell-matrix interactions. The system is integrated with an incubator, enabling long-term monitoring 
of cell attachment over substantial time scales (hours to days) without interruption of the culture 
environment. The key innovation enabling these capabilities is the use of noncoherent illumination 
of a photonic crystal biosensor and a spectroscopic scanning system that couples with a microscope 
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objective. Here, we demonstrate label-free time-lapse imaging of the attachment and chemotaxis 
of dental stem cells using PCEM. Single-cell movement and filopodial extension are easily 
identifiable, yielding significant potential for the future investigation of numerous cellular 
processes including tumor cell metastasis and stem cell differentiation. While still an in vitro 
environment, the elimination of cytotoxic fluorophores and reporter molecules allows for the 
controlled study of complex biological processes over extended time periods.  
4.2 Photonic crystal biosensor surface engineered specifically for cell attachment 
 Photonic Crystal (PC) biosensors have recently been demonstrated as a highly versatile 
technology for a variety of label-free assays including high-throughput screening of small 
molecule-protein interactions, characterization of protein-protein interactions, and measurement 
of cell attachment modulation by drugs128-130. A PC is a sub-wavelength grating structure 
consisting of a periodic arrangement of a low refractive index material coated with a high reflective 
index layer (Figure 1). When the PC is illuminated with a broadband light source, high order 
diffraction modes couple light into and out of the high index layer, destructively interfering with 
the zeroth-order transmitted light79. At a particular resonant wavelength and incident angle, 
complete interference occurs and no light is transmitted, resulting in 100% reflection efficiency. 
Figure 4.1 (a) Schematic diagram of the photonic crystal (PC) biosensor. A PC sensor is comprised of a replica 
molded polymer grating overcoated with a high refractive index thin film of TiO2. Inset: Photo of a PC fabricated 
upon a glass cover slip. (b) Scanning electron micrograph of the PC surface. 
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The resonant wavelength is modulated by the addition of biomaterial upon the PC surface, 
resulting in a shift to a higher wavelength. The electromagnetic standing wave that is generated at 
the PC surface during resonant light coupling inhibits lateral propagation, thus enabling 
neighboring regions on the PC surface to display a distinct resonant wavelength that is determined 
only by the density of biomaterial attached at that precise location. By measuring the resonant peak 
wavelength value (PWV) on a pixel-by-pixel basis over a PC surface, an image of cell attachment 
density may be recorded. PWV images of the PC may be gathered by illuminating the structure 
with collimated white light through the transparent substrate, while the front surface of the PC is 
immersed in aqueous media. 
 The advantages of PC-based surfaces for cell attachment imaging are compelling. As a 
label-free technology, cell attachment to a PC sensor is measured without the use of dyes or stains, 
so a population of cells can be measured repeatedly without disrupting their culture environment. 
The detected output signal is highly quantitative, providing measurements that are repeatable 
between sensors, instruments, and laboratories without photobleaching. PC biosensors are 
fabricated from inexpensive materials and require only low intensity illumination from beneath 
the sensor, so no electrical or physical contact between the sensor and the detection system occurs, 
and illumination does not pass through the cell body, the cell media, or the liquid-air meniscus of 
a microplate well. The PC biosensor strictly limits lateral propagation of resonantly coupled light, 
enabling imaging-based detection with resolution sufficient for measuring subtle variations in cell 
adhesion strength within a single cell, without needing to pre-tune the sensor to a particular 
resonant coupling condition, as in SPRi. PC biosensor imaging provides information that is 
fundamentally different than that provided by an optical microscope, as the sensor responds to 
local variation in cell attachment strength to the transducer surface. The sensor can be prepared 
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with a variety of surface functionalizations (such as matrix coatings, antibodies, and peptides) and 
thus can be used as a tool for measuring how cell attachment to surfaces is modulated by drugs, 
growth factors, or other environmental factors.  
4.3 Hyperspectral imaging microscope detection instrument 
 A schematic diagram of the PCEM instrument is shown in Figure 2.  The system is built 
upon the body of a standard microscope (Carl Zeiss Axio Observer Z1), but in addition to ordinary 
bright field imaging, a second illumination path is provided from a fiber-coupled broadband LED 
(Thorlabs M617F1, 600 < < 650 nm). The fiber output is collimated and filtered by a polarizing 
beam splitter cube to illuminate the PC with light that is polarized with its electric field vector 
oriented perpendicular to the grating lines. The polarized beam is focused by a cylindrical lens 
Figure 4.2: Instrument schematic of the PCEM. Illumination from a fiber-coupled LED is collimated and passed 
through a polarizing beamsplitter (PBS) to create a pure electric field polarization perpendicular to the PC grating. A 
cylindrical lens focusses the light to a line at the back focal plane of the objective. The PC resonantly reflects only a 
narrow band of wavelengths, which are collected through the entrance slit of an imaging spectrometer.  
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(f=200 mm) to form a linear beam at the back focal plane of the objective lens (10x, Zeiss). After 
passing through the objective lens, the orientation of the line-shaped beam is rotated to illuminate 
the PC from below at normal incidence. The reflected light is projected, via a side port of the 
inverted microscope and a zoom lens, onto a narrow-slit aperture at the input of an imaging 
spectrometer. The width of the adjustable slit was set to 30 µm for the work reported here. Using 
this method, reflected light is collected from a linear region of the PC surface, where the width of 
the imaged line, 1.2 µm, is determined by the width of the entrance slit of the imaging spectrometer 
and the magnification power of the objective lens. The system incorporates a grating-based 
spectrometer (Acton Research) with a 512 × 512 pixel CCD camera (Photometrics Cascade 512). 
The line of reflected light, containing the resonant biosensor signal, is diffracted by the grating 
within the spectrometer (300 lines/mm) to produce a spatially resolved spectrum for each point 
along the line. 
 Therefore, each pixel across the line is converted to a resonant reflection spectrum, 
containing a narrow bandwidth (Δλ ~ 4nm) reflectance peak from the PC. The Peak Wavelength 
Value (PWV) of each peak is determined by fitting the spectrum to a 2nd order polynomial 
function, and then mathematically determining the maximum wavelength of the function. By 
fitting all 512 spectra, in a process that takes 20 msec, a line comprised of 512 pixels is generated 
that represents one line of a PWV image of the PC surface. With an effective magnification of 26x, 
each pixel in the line represents a ~ 0.6 µm region of the PC surface and 512 such pixels cover a 
total width of ~300 µm. To generate a two- dimensional PWV image of the PC surface, a motorized 
stage (Applied Scientific Instruments, MS2000) translates the sensor along the axis perpendicular 
to the imaged line in increments of 0.6 m/step.  Using this technique, a series of lines are 
assembled into an image at a rate of 0.1 sec/line and the same area on the PC surface can be scanned 
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repeatedly. Each image is comprised of 512 by n pixels, where n can be selected during each scan 
session, and each pixel represents a 0.6 x 0.6 m region of the PC surface. A biosensor experiment 
involves measuring shifts in PWV. A baseline PWV image is gathered before the introduction of 
cells, when the PC is uniformly covered by cell media, which is aligned and mathematically 
subtracted from subsequent PWV images gathered during and after cell attachment. 
4.4 Characterization of the PC sensitivity and resonant wavelength stability under 
cell culture conditions 
In preparation for cell attachment demonstrations, the ability of the PCEM to measure 
shifts in the bulk refractive index of the cell media was established. First, exposing the entire PC 
surface to distilled water (n = 1.333) and subsequently exposing the same sensor to isopropyl 
alcohol (n = 1.377), we confirmed that an individual pixel within a PCEM image demonstrates 
high reflection efficiency and narrow resonant reflection bandwidth. The PWV shift measured 
from a single pixel exposed to both media yielded a bulk refractive index sensitivity of n = 
102 nm/RIU.  
 A series of PWV images were gathered over a 12-hour period to demonstrate PWV stability 
with the PC exposed to cell media at the elevated temperature (T = 37 ̊ C) and 5% CO2 environment 
used for biological studies. Ham’s F12 media (Invitrogen) was placed in a PDMS well attached to 
the PC surface. The average PWV shifted by only 0.12 nm over 12 hours, and the standard 
deviation of PWV within an image of a PC uniformly exposed to cell media was 0.09 nm. 
 The most commonly used method for identification of differentiating stem cells is the 
labor- and time-intensive methylcellulose assay, which only reveals the identity of the colonies 
weeks after commitment occurs131-133. Furthermore, this approach requires cells to be resuspended 
68 
 
in liquid phase, thereby altering many of the environmental cues that yielded the observed 
differential development. Using PCEM, it is possible to capture the dynamics of cell morphology 
and cell-matrix interactions during complex processes such as stem cell differentiation under real-
time conditions (with less than 60 seconds between subsequent images). Such a tool would be 
critical for examining the potential of cell attachment signatures as a proxy for stem cell lineage 
commitment, particularly considering such analyses could be performed without disturbing the 
extracellular environment.  
 As cells attach and spread, positive PWV shifts are observed due to an increase in the 
concentration of cellular material within the evanescent field region of the PC.  A PWV image for 
human pancreatic cancer cells (Panc-1) is compared to a brightfield image of the same cells in 
Figure 4.3. Morphological profiles are consistent with healthy, attachment-dependent cells. 
Representative spectra are shown from inside and outside the cell region, demonstrating a 
definitive whole-spectrum shift of the characteristic resonant peak. Clearly visible boundaries of 
~ 0.5 nm PWV shifts demonstrate the ability of PCEM to provide information about the geometry 
of attachment, which has been shown to have significant implications for both the classification of 
differentiating stem cells134, and the metastatic potential of tumor cells135. In addition, sub-cellular 
variation of PWV is indicative not only of the presence of cellular adhesion, but also modulation 
in the strength of attachment. For example, cell ‘2’ in Figure 4.3 shows a gradient in cell attachment 
strength from left to right. A region of greater PWV shift along the leading edge suggests the 
formation of lamellipodia, indicating a higher concentration of intracellular matter than is present 
in the rest of the cellular attachment footprint. As it can be assumed that the majority of this lower-
PWV shifted footprint occurs under regions of cytosol, the increased PWV of the cell boundary, 
especially in these protrusions, most likely can be attributed to the formation of actin bundles at 
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sites of focal adhesion, a process thoroughly documented via traditional, yet cytotoxic, fluorescent 
staining techniques.136-138 
4.5 Label free imaging of stem cell attachment and drug-induced apoptosis 
 Next, murine dental stem cells (mHAT9a) were cultured and allowed to attach to a PC 
surface prepared with fibronectin over a period of two hours (Figure 4.4a). From the series of PWV 
Figure 4.3 (a) Bright field and (b) PWV imaging of Panc-1 cells attached to the PC surface. Cells were seeded 
onto a fibronectin-coated sensor and allowed to incubate for 2 hours before imaging. Lamellipodial extensions are 
visible, especially from cell 2, demonstrating the ability of PCEM to resolve regional differences in single-cell 
attachment. Darker shading indicates regions of higher protein concentration, and is present in regions near the 
boundary of lamellipodia formation, consistent with the creation of actin bundles. (c) Representative regions of 
cellular attachment. Selected areas of the PWV image from beneath a cell show the PWV shift of a typical Panc-1 cell 
is ~1.0 nm, and consistent throughout the entire spectrum at those locations.   
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images gathered at 3 minute intervals, initial attachment times can be identified within the 3-
minute period of image acquisition. Cells are observed attaching to the treated surface, with initial 
attachment characterized by small, round areas of PWV shift, consistent with spherical cells 
exiting suspension. As time progresses, average cell diameter increases, and membrane boundaries 
become more irregular as cellular processes begin to extend from cell bodies. Many cells maintain 
highest shifts at their periphery, which is consistent with the high concentration of cytoskeletal 
protein necessary for boundary maintenance and lamellar extension139. Random locomotion is 
observable, which reveals that cellular detachment results in a full recovery of initial PWV values 
when a cell moves to a new location. We observe no preference for the cells to extend themselves 
or to move along the direction of the PC grating. 
 Cellular apoptosis and detachment were also studied. Using another fibronectin-treated PC 
biosensor, mHAT9a cells were allowed to attach to the sensor surface for 3 hours. A final 
concentration of 2  staurosporine, shown to induce apoptosis via protein kinase inhibition140,141, 
was added to the cell chamber and mixed for 15 seconds. Cells were imaged every 20 minutes for 
18 hours (Figure 4.4b). Initial cells appear healthy, with various filopodia extending radially from 
cell bodies. As time progresses, the footprint of the cell bodies decreases, and several of the cells 
appear to detach completely. Other cells appear to undergo apoptosis prior to detachment, leaving 
behind remnants of cell membrane, which still produce a detectable PWV shift. The breakdown 
and modification of cell-cell and cell-ECM interactions is of great importance to answering 




Figure 4.4 (a) Time lapse PWV images of cellular attachment of mHAT9a cells. Cells were seeded at 20,000 
cells/ml on a fibronectin-coated sensor surface. After 3 minutes, regions of initial cell attachment appear as small, 
round regions, consistent with spheroid, trypsinized cells coming out of suspension and attaching to a surface. As 
time progresses, both the size of the cells and intensity of the PWV shift induced by them increases, indicating a 
higher localization of cellular material at the sensor surface, which can be expected during cell spreading. Finally, 
once cells are sufficiently attached, cellular processes can be observed sensing the cells’ microenvironment in all 
directions. The outer irregular boundaries of the cells have a relatively low PWV, consistent with thin, exploratory 
filopodia, accompanied by a more heavily attached region slightly immediately adjacent in the cell interior, likely 
a result of actin bundle formation. (b) Time lapse PWV images of mHAT9a apoptosis and detachment. Cells were 
seeded at 8,000 cells/ml onto a fibronectin-coated sensor surface. Cells that detach can be observed by the gradual 
retraction of filopodia and overall cell rounding before the PWV shift disappears entirely. Some cells appear to 
undergo apoptosis while still attached, leaving remnants of cell membranes and protein on the sensor surface. 
ΔPWV data was attained via background subtraction from initial image taken before cell attachment (t = 0).  
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PCEM is unique in the fact that the biosensor response is a direct quantification and 2D localization 
of attachment at the single cell level, as opposed to indirect methods of staining for actin bundle 
formation or even ensemble averaging of bulk dielectric properties. This direct observation 
available over a time scale of hours to days provides a natural tool for the future study of cancer 
cell detachment and metastasis.  
4.6 Label free imaging of stem cell chemotaxis 
 We next sought to validate the use of PCEM imaging in examining cell-mediated 
chemotaxis. The importance of stromal cell-derived factor-1 (SDF-1α) in the directed chemotaxis 
of differentiating cells is well-known for a myriad of situations including hypoxic ocular 
neovascularization, capillary formation and adipocyte differentiation in human adipose tissue, and 
bone regeneration in traumatic brain injury142-144. More recently, SDF-1α and its effect in attracting 
CXCR4 receptor positive cells have been investigated in dental healing and regeneration. 
However, current mechanisms for studying the recruitment of dental stem cells have been based 
on fixing and staining cells145,146. As the observed migration occurs on the order of days, label-
based assays are not feasible for extended time course studies. PCEM provides an opportunity to 
monitor such events as they occur. 
 We examined mHAT9a chemotaxis in response to beads soaked in SDF-1α, a 
chemoattractant to which the receptor CXCR4 is sensitive147 (Figure 4.5). After a bead was placed 
on the sensor surface, attached cells were observed to move in the direction of the eluting bead. 
Probing lamellipodia extend in multiple directions around the cell, but only projections formed in 
the direction of the bead are maintained by the migrating cells. Attachment in the trailing edge of 
the cell decreases over time as the cell bodies proceed in the direction of chemotaxis, resulting in 
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a return of the sensor to its native state. The experiment was repeated with a mHAT cell line with 
a constitutive knockout of the CXCR4 coding gene, and no directional movement was observed. 
This suggests that the observed cellular movement was indeed due to chemotaxis, as opposed to 
nonspecific locomotion. Critically, we do not observe preferential movement or extension of cell 
processes in the direction of the PC grating lines. To our knowledge, this represents the first label-
free time-lapse imaging of the attachment localization of living cells during chemotaxis.  
 It has been shown that SDF-1α/CXCR4 mediated recruitment of dental stem cells is likely 
an important inflammatory response and underlying promoter of reparative dentin formation148. 
Further investigation of the SDF-1α/CXCR4 pathway with the PCEM technology could provide a 
valuable investigation of morphological changes induced by the inflammatory response of dental 
stem cells to dental damage.  
Figure 4.5 (a) Time lapse PWV images of chemotaxis of mHAT9a cells. Cells were deposited on the sensor 
surface at a concentration of 8,000 cells/ml and allowed to attach for 2 hours before imaging. An agarose bead 
was placed at a location approximately 100 microns above the top of the image, and PWV images were collected 
every 20 minutes after the bead was placed. Cell movement direction is indicated with an arrow in the leftmost 
frame. (b) CXCR4 knockout cells exhibit non-directional movement on the sensor surface. Similarly prepared, 
CXCR4 mutants do not show directional movement toward the bead, demonstrating that the previously observed 




PCEM represents a new imaging modality that can be easily integrated with a conventional 
optical microscope to enable quantified, near real-time, high resolution imaging of cell-surface 
interactions. While traditional microscopy techniques such as phase-contrast and DIC provide 
basic information about cellular morphology and general appearance, PCEM provides information 
that is specific to the interface between the cell and its substrate.  By virtue of the surface-confined 
resonant electric field of the photonic crystal, PCEM enables high contrast imaging of the 
interaction strength of cells with a surface, providing a specific attachment footprint as opposed to 
a generalized shape of the entire three-dimensional cell body. The approach utilizes low power 
illumination from a visible wavelength LED from below, using a PC sensor structure that can be 
incorporated into standard coverslips (as demonstrated here), microscope slides, or microtiter 
plates that are typically used for cell research. PCEM clearly demonstrates that cell-surface 
attachment strength is not uniformly distributed within a cell or static as a function of time, but 
instead contains rich dynamic information that includes the rate of cell boundary extension, the 
size of a cell “footprint” on a surface, and the effect of the extracellular environment (including 
chemotactic gradients) on cell attachment.  
 The cell imaging experiments used to demonstrate PCEM were selected to show that the 
spatial resolution of the approach is sufficient for clearly observing features such as spatial 
gradients in cell-surface attachment and the extension of fine-structured filopodia, attributes that 
are typically observed only using dyes or stains. As a label-free detection approach, PCEM enables 
continuous monitoring of these phenomena over extended time periods that are compatible with 
the biological time scales of chemotaxis, apoptosis, differentiation, and proliferation. This work 
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demonstrates, to our knowledge, the first time-lapse movies of cell-surface interaction monitoring 
at these time scale.  
 It is already well-established that both the comparison of cancerous/non-cancerous cells 
and of cell lineages differentiated from pluripotent stem cells lend themselves to investigation via 
their unique morphologies and cellular attachment protein expression, with the majority of such 
differences easily visible via traditional microscopy.  With PCEM, cellular attachment morphology 
can be directly observed, and attachment ‘profiles’ for different cell types can be developed.  By 
limiting the study of cell morphology to the specific density of cellular material present in the 
evanescent field region of a photonic crystal, attachment can be observed in a more direct method 
with less subjectivity than simple qualitative observation using traditional microscopy methods.   
 There is an increasing awareness of the importance of cellular adhesion and the mechanical 
microenvironment of cells on their behavior, yet directly measuring these attributes in a non-
invasive fashion has proved difficult. PCEM provides a novel, robust methodology for the 
investigation of these attributes in a controlled environment without chemical alteration. The 
relationship between mechanical microenvironmental cues and cancer cell behavior has been 
demonstrated, contributing significantly to tissue dysplasia and metastatic detachment149. With 
PCEM, it will be possible to investigate important components within the progression of tumor-
development, such as the recruitment and movement of neutrophils to the cancer 
microenvironment. Neutrophil polarization and chemotaxis represents a challenging process to 
study as it presents a complex and dynamic set of cellular-ECM interactions. Near real-time 
imaging would allow for rapid improvement in our understanding of this and the other biological 




 Similarly, the resolution demonstrated in this chapter with which subcellular localization 
of filopodia and focal adhesions were observed provided the first suggestion that other biodetection 
opportunities requiring high spatial resolution might be possible.  In combination with the 
previously demonstrated smartphone-based spectrometric optics, I began thinking about specific 
point-of-care clinical challenges that remained unsolved that might be addressed with a portable 




CHAPTER 5: HIV DETECTION USING PCEM FOR POINT-OF-
CARE TESTING 
5.1 Introduction 
In Chapters 2 and 3, I demonstrated the full design cycle from ideation through prototyping, 
and a successful handoff to a corporate partner who will commercialize the technology.  In Chapter 
4, I describe the use of PCEM as a new technology to further enhance the sensitivity of the PC-
modality of spectral biosensing by re-introducing the second spatial dimension.  In this chapter, I 
seek to apply the same PCEM technology to a specific point-of-care application that would 
significantly benefit from the increase in sensitivity resultant from digital detection of individual 
nanoscale attachment events.  To this end, this chapter will begin with specific background 
information on HIV viral load testing, and why it is ideally suited for development as a PCEM-
based digital-detection assay.  Then, demonstration of the single-particle resolution of the 
benchtop PCEM setup will be described and validated with non-HIV antibody capture 
experiments.  A thorough discussion of the HIV Env protein is included to provide important 
context and relevant background for the second experimental section (Section 5.4) where HIV 
viral attachment events will be investigated.  At the end of the chapter, a discussion of important 
considerations relevant to the design of the portable PCEM instrument will be included based upon 
1) optical design considerations from Chapters 2 and 3, 2) human factors considerations from 
Chapter 4, and 3) practical considerations from both the usage case of the eventual device (Section 
5.1) and the physical structure of HIV (Section 5.3). 
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5.1.1 Background and Motivation 
 HIV/AIDS has presented itself as one of the most serious public health challenges facing 
the world today 150. Since its emergence as a global pandemic 30 years ago, AIDS has claimed the 
lives of over 25 million people and increased global disability-adjusted life years (DALYs), a 
measurement of global disease burden, by 351% over the past 20 years 151. Having recognized 
HIV/AIDS as a true pandemic, initiatives such as the President’s Emergency Plan for AIDS Relief 
(PEPFAR) and the UN Millennium Declaration have specifically targeted reversal of the spread 
of the disease as a key area to improve the health, economic security, and overall wellbeing of the 
global population 150,152. While great strides have been made toward reversing the spread of HIV 
infection, it remains a significant threat to global health with over 35 million people currently 
infected, and remains the leading cause of mortality of young women in low- and middle-income 
countries 153,154. In addition to a heavy gender-discrepancy in burden, the disease is 
disproportionately found in sub-Saharan Africa, which accounts for 69% of the global population 
living with HIV but only 12% of global population 150. Increasing access to antiretroviral therapy 
(ART) is a leading cause of the decrease in AIDS-related deaths 155. Plans to increase the 
penetration of available treatment to areas of high disease burden are ongoing, but often the 
infrastructural requirements and cost-prohibitive nature of current diagnostic equipment needed 
for proper treatment selection and monitoring prevents successful deployment of such strategies 
in primary and secondary-level facilities.   
 HIV viral load (VL) has long been known to provide meaningful clinical information about 
the progression of infection and development of AIDS by directly quantifying the number of virus 
particles present in patient blood 156-158. Current methodologies used in commercial diagnostics 
rely heavily on nucleic-acid quantification via PCR to quantify the number of virus particles. 
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Nucleic acid quantification tests have been demonstrated as successful tools for measuring VL, 
but prohibitive features such as equipment cost, infrastructure demands, and technical expertise 
requirements make these gold-standards inadequate for the developing world 159-161. A few enzyme 
linked immunosorbent assay (ELISA)-based tests have been developed to measure HIV RNA or 
RNA-associated proteins, such as the Cavidi ExaVir RT and PerkinElmer ultrasensitive p24 
assays; however, these tests have received mixed reviews in regard to their high measurement 
variability and lack of sensitivity 162,163. 
 In addition to being able to detect the initial contraction of an HIV infection and risk of 
transmission to others in real time, VL measurement has been demonstrated as a key indicator for 
the monitoring of ART. For years, CD4+ T-cell levels and clinical observation were used as 
diagnostic indicators for treatment failure of antiretrovirals. These are still important tools for 
assessing the overall degradation of a patient’s immune response, but due to the higher sensitivity 
and potential for earlier detection of treatment failure, VL has emerged as an increasingly 
important component of current and future ART monitoring strategies 164. Beginning in 2010, VL 
testing became the WHO-preferred approach to ART monitoring whenever possible and, with the 
adoption of the WHO June 2013 Consolidated ART guidelines, became the only clinical approach 
to be recommended for assessing virologic failure and beginning second-line treatment 154,155. 
These guidelines suggest initial VL testing after 6 months of ART and annually thereafter. Upon 
a measurement of VL greater than 1000 copies/mL, a second VL test administered after a three-
month period of strict ART adherence is considered justification to switch ART regimens in all 
patient populations.  
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5.1.2 Limitations of Current Techniques for the Point-of-Care 
Current standard-of-care tests in the US present lower limits of detection at 20 copies/mL.  
When translated to a point-of-care context, several significant challenges become evident.  
Standard blood plasma collection volumes for tests run on platforms such as the Abbott Xpert, 
Hologic Aptima, and Biomerieux NuliSens range from 1 to 1.2 mL, while a large finger prick can 
generate about 100 µL, resulting in a 20x decrease in plasma volume, and therefore RNA copies, 
for a point-of-care test.  While further optimization may be possible, fundamental limits of PCR, 
such as the “Monte Carlo” effect, and even individual enzyme efficiencies165 are likely already 
contributing factors.  Assuming that 20 copies per PCR reaction is at the limit of what can 
reproducibly be quantified, the decrease in volume would result in a comparable amount of 200 
virions per mL of whole blood, or 20 virions per 100 µL sample. 
 At 200 virions/mL, this represents a concentration in the sub-femtomolar range, which is 
beyond that of even the newest serological detection methods.  The Quanterix SimoaTM system 
and the Singulex Erenna system and similar emergent high-end serology-based biosensing 
platforms have demonstrated detection down to the femtomolar range, but no less.166-168 All of 
these systems all rely on some sort of signal amplification, be it enzymatic of replication-based.  
Just as PCR and other nucleic acid amplification techniques have demonstrated, when nearing the 
lowest limits of detection, any sort of amplification will introduce some noise and uncertainty into 
the measurement as at such low concentrations particles follow a Poisson distribution.  
 When discussing 20 virions per 100 µL sample, this leaves us looking for techniques that 
can identify each and every particle attachment event.  Such “single particle” sensors have been 
demonstrated, and consist of two broad groups: imaging and non-imaging platforms, many of 
which the Cunningham group recently described in a review published in Chemosensors.169  Such 
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single-particle detection techniques are optimal for situations such as point-of-care HIV viral load 
monitoring when simplicity of assay design (no thermocycling, no primer design, fewer reagents, 
etc.) and low-variability at low concentrations.  Having already demonstrated sub-micron spatial 
resolution of cellular attachment processes, a logical next step is detecting single binding events 
using PCEM. 
 By utilizing plasmonic nanoparticles that absorb maximally at the resonance condition of 
a PC, spatially-resolved images of binding events can be monitored via repeated PCEM scanning, 
much as cellular attachment was, but at a smaller scale.  In this chapter, I will first demonstrate the 
ability to detect single-attachment events using a standard serological binding event, I will then 
move on to discussion of the HIV Env protein, the only non-host material present on the external 
surface of an HIV virion, and will then present recent work on detecting and validating single HIV 
virion binding events via PCEM, which will inform the subsequent validation of antibody-HIV-
antibody-nanoparticle complexes present on the PC surface and visible in PCEM images.   
5.2 Single Nanoparticle Detection 
In the sub-micron size regime, typical gravitational and buoyancy forces on particles (both 
HIV and nanoparticles) become secondary to diffusion, which has timescales of minutes to hours.  
As a result, one of the most important considerations for a POC device for viral load management 
that maximizes the capture of virions in a sample is the microfluidic channel height of the capture 
region, which strongly affects the particle settling time.  This dimension, coupled with the width 
of the channel, the flow rate, and cross-sectional area, collectively determine the shape and size of 
the depletion zone around the sensor.  For a useful primer on balancing fluid dynamic and mass 
transport considerations in the microscale regime, the reader is directed to a paper with several 
relevant, practical examples.170 
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To serve as a starting point for 
experimentation, COMSOL simulations 
were run with a variety of sensing 
geometries, and optimal starting 
parameters were identified (Figure 5.1).  
Simulations were run to understand the 
improvements to LOD that could be made 
by using a microfluidic device, compared 
to an experimentally-derived one, as 
previously reported for the static capture 
of HIV.82    There were two key 
considerations for determining the 
sensor’s theoretical LOD: a direct 
improvement of the previously achieved 
surface density (0.65 virions/mm2, 
COMSOL), and capturing enough 
particles at the LOD to generate a reliable 
signal assuming at least 50% capture(3-8 virions). Based upon simulations, the optimal sensor 
should be 2-3mm in width with a height as short as possible (10µm was determined to be at the 
low-end of what might be possible to physically construct).  At concentrations relevant for HIV 
viral load, it is crucial to minimize the fraction of cross-sectional area of the microfluidic channel 
that does not allow HIV passing through it to interact with the sensor surface.  Manufacturing such 
a short, wide channel is an engineering challenge in-and-of-itself, and in parallel to preliminary 
Figure 5.1. COMSOL modeling results. A. Representative 
image from microfluidic model showing time and position-
based concentration gradients. B. Model used for representative 
384-well plate well.  Incredibly large height dimension, 
compared to that of surface area at the biosensing surface 
(bottom) presents a hydrodynamics challenge for attachment of 
virions to the surface. C. LOD for sensors of various parameters. 
In Region I, LOD is governed by a fundamental critical number 
of required virions present across the entire sensor, (orange, 
gray, and yellow dashes for critical number = 1, 3, 8 virions, 
respectively). In Region II, LOD is determined only by the 
surface density of captured virions, as in 167, (blue dashes). The 
optimal LOD for any critical number of viruses is the minima 
located at the intersection of Regions I and II. 
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experiments discussed in this section, the development of the microfluidic device was initiated 
(Section 5.4.2). 
To demonstrate the concept of single nanoparticle detection, we set up a simple serological 
capture assay with minimal biosafety concerns (Figure 5.2).  A PC sensor was silanized with (3-
Glycidyloxypropyl)trimethoxysilane (GPTMS), resulting in epoxide rings which will 
indiscriminately attach to any exposed primary amine group on proteins.  A PDMS gasket was 
attached to the sensor surface with two wells, an active area and a control (Figure 5.2 inset). Next, 
mouse IgG antibody was incubated on the surface overnight, and then washed with PBST three 
times.  The prepared sensor was placed on the PCEM and scanned.   
Figure 5.2 Detection scheme for proof-of-concept single nanoparticle attachment.  Murine IgG is 
immobilized via epoxysilanization, and hircine anti-mouse IgG is linked to gold nanourchins via SH-PEG 
linkers.  Figure is drawn approximately to scale.  Inset: PDMS gasket for location-specific functionalization. 
84 
 
Detection nanoparticles were prepared using commercially available gold nanourchins 
(Sigma).  Briefly, goat anti-mouse IgG was linked with SH-PEG via NHS, EDC chemistry.  After 
successful functionalization with SH-PEG, the resultant SH-PEG-IgG solution was mixed with 
gold urchins.  The ideal volume of Sh=PEG-Ab was determined to be approximately 12 µL via 
DLS, corresponding to a 12-nm bathochromic shift in absorbance peak for the nanourchins.  
Functionalized nanourchins were incubated on the sensor, and serial scans were completed twice 
per hour.  After between two and three hours, the nanourchins were removed, and the sensor was 
once again washed 3x with PBS.   
Next, the sensor was observed via SEM, and patterns of attachment were observed (Figure 
5.3). In the inset of the figure, an overlay of the SEM and PCEM images shows clear recognition 
of each of 7 nanoparticles in the PCEM image.  Spreading in the direction orthogonal to the PC 
grating is a result of the PCEM stepper motors used, which can only move in increments of .1 nm, 
whereas the “true” step distance to achieve a square ‘pixel’ is .16 nm.  For all scans discussed 
subsequently, a .1 nm step size was utilized, resulting in images that must be stretched by a factor 
of 1.6 in image postprocessing. 
Clearly the reliance on minor defects or holes in the PC surface as landmarks is not ideal, 
so a gridded pattern to track spatial location on the macroscale for correlation between PCEM 
images and SEM (as well as between steps that require the sensor to be removed from the 
microscope, as required by BSL2+ safety protocols for future HIV work) was devised.  A 
photomask was designed with a grid pattern (Figure 5.4), and transferred to the surface via 
photoresist patterning, exposure, and removal of some of the PC’s TiO2 layer (Figure 5.5).  The 
resultant device allows for the 2D location to be recorded using a labeled coordinate system of 
etched “pixels” so that any 50 µm2 scan area will be within 50 µm of a coordinate location (fine 
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grid, for use with 40x objective).  The coarse grid is for possible use with a 10x objective.  Grids 
were centered at distances to match the locations of the centers of wells in the PDMS gaskets used 
for functionalization and incubation.  Once grids were tested and validated on the PCEM and SEM, 
we prepared to begin experiments with HIV-based chemistry. 
Figure 5.3 Validation of PCEM Images with SEM. A. SEM, B. PIV image from PCEM and C. Composite 
image of the same location on a PC.  Defects used to align images from different sources are circled in each 
image.  The top two images are the unaltered images resulting from data acquisition using each platform.  C. 





Figure 5.5 Fabrication procedure for etched grid for photonic crystals.  
Figure 5.4 A. Photomask design and pattern. B. Coordinate system for each grid. C. PIV and D. PWV images of 
patterned grid on a PC 
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5.3 The HIV Env Protein Complex 
As direct-detection of HIV is not a standard method of quantification, it is important to 
have a thorough understanding of the underlying structure and function of the target protein for 
viral capture, the Env protein.  Knowing that HIV persists as a latent infection in spite of immune 
responses, and that the Env protein is the only viral protein expressed on the surface, I performed 
a thorough review of current work relating to the structure, action, and function of the protein as 
it facilitates host-cell attachment, entry, but also immune-avoidance.  
The surface of HIV is comprised of a lipid bilayer assembled from the host cell with 
multiple copies of a protein spike, Env, which facilitates its tropism, attachment, and entry.  These 
spikes are made of a mushroom-shaped trimer of heterodimers of proteins gp120 and gp41, which 
are generated from a common gp160 precursor, and comprise the surface (SU) and transmembrane 
(TM) portions of the spike, respectively (Figure 5.6).171  These spikes are assembled as part of the 
outer membrane via the cytoplasmic domain of gp41 (gp41CD) which serves to target mature 
gp160 to inner-leaflet-tethered developing virions.  This gp41CD region is also responsible for 
minimizing the amount of Env expressed on the cell surface.  By having endocytotic motifs that 
interact with clathrin pits,172,173 the envelope protein itself is able to maintain a low level of 
expression to maximize evasion of the immune system.  While this strategy does decrease potential 
for immune recognition, the most significant component of successful HIV Env-based evasion of 
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5.3.1 Structure of Env 
HIV gp160 is a precursor protein containing both proteins necessary for forming the Env 
structures present on the surface of a mature virion.  In the Golgi, this protein is cleaved by a furin 
protease, allowing the resulting gp120 and gp41 to organize into heterodimers, and then collect 
during virion formation into trimers resulting in a final, mature Env.174 Functionally, gp41 serves 
two purposes: membrane anchoring, and mediating membrane fusion with the host cell.  Non-
covalent bonds serve to attach gp120 to gp41, which functions as the interface between the virion 
and the outside world, responsible for host-cell recognition and immune system evasion.  
Figure 5.6 A) Schematic of the env protein. TM and SU components are shown, as is basic structure. Rusert, 
adapted B) Surface profile of the three faces of the gp120 core monomer. The gp120 core is seen from the 
perspective of CD4, and is oriented with the viral membrane at the top of the figure and the target cell membrane 
at the bottom.189  C) Domains of HIV-1 Env. The gp140 precursor is cleaved into the surface subunit (gp120) 
and transmembrane subunit (gp41) in the Golgi complex at the furin site indicated. gp120 contains five variable 
domains (V1-V5) and five constant domains (C1-C5). gp41 consists of an extracellular domain, containing the 
fusion peptide (FP), and the heptad-repeats (NHR and CHR), a membrane-spanning domain (MSD), and a 
cytoplasmic domain (CD).176, adapted 
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Structural elucidation of gp120 has historically been of significant interest to scientists 
interested in vaccine design.  However, one of the unique attributes of HIV that makes it so 
successful at immune evasion also has historically confounded attempts to determine its structure: 
the remarkable physical flexibility of the protein and ability to adopt multiple confirmations with 
significant differences in shape and relative distances between subcomponents.175-178 The primary 
structure of gp120 can be described as five constant domains, which are highly conserved and 
responsible for the binding of CD4, interspersed with five variable domains, which are responsible 
for the broad heterogeneity resulting from the rapid rate of genetic mutagenesis (Figure 5.6C). 
Most of these variable domains are separated from the rest of the protein with disulfide bridges of 
cysteine-cysteine residues, which help in the tertiary folding of the protein.174  
The primary functions of gp120 are to target HIV to its preferred host cells (CD4+ T cells), 
and to evade a host immune response.  Though some work has demonstrated CD4-independent 
entry of HIV,179,180 the most common process begins with CD4 binding of a highly conserved pit 
in the core of the protein, which introduces a conformational change in the Env protein, which 
both reveals the secondary binding site for a targeting coreceptor (either CXCR4 or CCR5), and 
induces changes in the gp41 fusion machinery.178  
The first successful model of gp120 was published in 1998 in an article and letter in Nature 
by Kwong and Wyatt.177,181 This model introduces the concept of three functional faces of the 
protein: one that is immunologically active (neutralizing), one that is immunologically silent, and 
one that is only accessible in a dissociated form (non-neutralizing) due to interactions with gp41 
(Figure 5.6B,C).181 While it has since been shown that the exposed faces of gp120 are significantly 
dynamic in nature and so do not lend themselves to easily demarcated categorization, it is 
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beneficial to understand the functional principles of these faces, as they confer a basic framework 
for the three principle methods of gp120-based host-immune evasion. 
5.3.2 Cloaking of Env 
The ‘silent’ face of the protein actually constitutes a large portion of gp120, and is a direct 
result of heavy glycosylation, effectively shielding it from host immune responses.  These sugars 
constitute approximately 50% of the molecular mass of Env (Figure 5.6),182 and are of a 
heterogeneous nature.  Oligomannose moieties are added to the precursor protein during 
translation in the endoplasmic reticulum, and are differentially modified in the Golgi, yielding a 
mixture of oligomannose and more complex N-glycan carbohydrates present on the surface of the 
mature protein.183  
The development of viable, mature, properly folded Env protein requires unmodified 
oligomannose, but the presence of these moieties alone would normally elicit a strong endocytotic 
uptake and endolysosomal degratory  response by dendritic cells.184 In contrast, the presence of N-
glycans on the surface is able to redirect the uptake of HIV by dendritic cells to an alternate 
pathway that transports HIV particles inside microvesicles, avoiding the degratory pathway, 
leading to eventual presentation of intact virions to CD4+ T-cells.183,185 This process, based upon 
the DC-SIGN lectin, has been described as a novel method by which HIV is able to hijack the host 
immune system, as it facilitates the transport of HIV particles during initial infection from mucosal 
surfaces to secondary lymphoid tissue, where the particles are presented to CD4+ T-cells, the target 
cells for HIV infection.186,187 As these interactions are not specific to a single glycan, but rather 
the relative concentrations of them, and the fact that these carbohydrates seem to exhibit a 
significant amount of clustering based upon hydrogen bonding of nearby moieties,188 the virion is 
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able to retain significant flexibility in the external surface features of the glycosylated regions of 




Figure 5.7. A) Glycan Shield of gp120. Density is shown in light blue for the cryoelectron microscopy 
tomogram of the HIV-1 spike.25 This has been fitted with the crystal structure of the HIV-1 gp120 envelope 
glycoprotein,180 with N-linked glycosylation shown in cyan as space-filling spheres and polypeptide 
backbone displayed in ribbon representation and colored grey for inner domain, red for outer domain and 
blue for bridging sheet. Modelled N-linked glycan is displayed as light blue.228 B, C) Oligomannose-
enriched virus colocalizes more strongly with internal endocytic markers compared with wt virus. Dendritic 
cells were loaded with fluorescent GFP-labeled virus (green) in the absence (wt) or presence of kifunensine 
(kif) for 2 h. Nuclei (blue) and different marker proteins specific for cellular compartments of iDCs were 
stained (pink); colocalization (white) with fluorescent HIV-1 (green) is indicated by arrows.  A relatively 
small amount of HIV was clustered with EEA1 (~3%) and CD63 (~4%), which mark early and late 
endosomes, respectively. Oligomannose-enriched virus colocalized more consistently with both EEA1 and 
CD63 (~8 and ~12%, respectively). The relatively low colocalization of both viruses with EEA1 and CD63 
may be, in part, a consequence of fast transit through these compartments, but the colocalization of 
oligomannose-enriched virus with these markers was consistently higher.185, Adapted 
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More than just providing a scaffold for a multifunctional glycan shied, the structure of 
gp120 itself also confers multiple methods of host immune response evasion.  While even early 
structural analyses of gp120 recognized major conformational changes likely took place,177 
understanding the full picture of complex interactions that take place to move between the 
unliganded189,190 and CD4-bound conformations has taken a substantial amount of 
effort.176,177,191,192  Initial limitations in crystallization methods were surpassed, and as more 
complete Env isolates were successfully studied, less uncertainty about peripheral structures 
existed, particularly near the gp41 attachment point.  The current model for gp120 relies on two 
domains: the inner and outer domains, referring to the location of the domains with respect to the 
central axis of the trimeric complex in vivo.  The inner domain is composed of a beta-sheet ‘clamp’ 
sub-domain responsible for interfacing with gp41 and three layered structures emanating from the 
beta-sheet region as separate loops.  These layers can effectively move past each other to rearrange 




Figure 5.8. “Layered” gp120 architecture A) The newly defined 7-stranded β-sandwich is shown in ribbon 
diagram representation (red) with β-strands labeled and loop excursions to the layers depicted schematically with 
layer 1 in violet, layer 2 in cyan, layer 3 in blue, and the outer domain in light brown. B,C) β-Sandwich clamp 
and embracing N and C termini of gp120 are shown holding gp41 in a metastable state. The layers, meanwhile, 
can refold to position the relative orientations of three highly glycosylated components: β-sandwich, V1/V2 
loops, and outer domain. In the unliganded state (B), the glycan-bearing elements arrange to form an effective 
“glycan shield” that prevents recognition by most antibodies. In the CD4-bound state (C), the layers organize 
with outer domain to form the high-affinity binding sites for CD4 and coreceptor.170 
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 Variable loops, V1 through V5, 
provide high levels of mutability, and 
exist on the external faces of gp120.  V3 
emanates from the distal, inner tip of the 
outer domain and is not glycosylated, 
and has been known to be a significant 
source of immunologic response since 
the early 1990s.196 It has been shown to 
specifically direct the choice of 
secondary receptor toward either CCR5 
or CXCR4, based upon the amino acids 
at the 11th and 25th positions.197 The 
structure has been elucidated as a beta-
hairpin tipped loop that extends 
independently from the gp120 body after 
CD4 binding, with highly conserved 
regions at its tip and base utilized for interaction with two separate domains of the coreceptor 
(Figure 5.9A).     
Though it is not glycosylated, V3 participates in an important immuno-evasive structure: 
the unliganded trimeric structure of the gp120 glycoprotein.194 Mao, et al. has shown that a highly 
structured union centered on the trimeric axis serves to stabilize the trimer as well as remove any 
access to either gp41 or the functionally active components of the inner domain.  V3, along with 
the V1/V2 loop, engage in gp120-gp120 interactions to stabilize the unliganded state of Env.195 
A) B)
C) D) E)
Figure 5.9. A) V3 in the context of a trimer at the target cell 
surface. The structure of the CD4-triggered gp120 with V3 
was superimposed onto the structure of four-domain CD4 
and the trimer model obtained by quantification of surface 
parameters. B) Schematic of coreceptor interaction.  V3 (red) 
is shown with its conserved base interacting with the sulfated 
CCR5 (green) N terminus and its flexible legs allowing its 
conserved V3 tip to reach the second extracellular loop of 
CCR5.193 C) The segmented local densities of gp120 that 
associate near the trimer axis are shown as solid surfaces 
wrapped in a meshwork representing the overall Env trimer, 
viewed from the perspective of the target cell, (D) as viewed 
from the perspective of the viral membrane and (E) as 
viewed from an angle parallel to the viral membrane. Three 
arms extend from the V3 base of each gp120 subunit toward 
the trimer axis and appear to support the central triangular 
junction. (c) The gp120 trimer-association domain segments 




This stabilization is important as the CD4-bound conformation of Env is the thermodynamically 
favorable position.190,198 While difficulties in determining complete structures for V1/V2 and V3 
domains persist, there is reasonable consensus that these interactions are occurring at the distal 
apex of the protein spike.194,195,199-201 Functionally, it has been determined that V1/V2 interaction 
with V3 likely occurs as a trimeric unit, where the V1/V2 domain of a single gp120 interacts with 
the V3 domain of an adjacent gp120 (Figure 5.9B).200 Furthermore, the differences in the stability 
of this unliganded trimer likely has significant clinical implications, as any changes to these 
regions seem to directly affect infectivity.  One interesting hypothesis is that the relative instability 
of the unliganded form202 is an evolved instability not present in HIV-2, which might be a reason 
that infectivity of that subtype is significantly lower than the more highly-CD4-dependent HIV-
1.203 Mutagenic modulation of the strength of these interactions is an important consideration for 
neutralization targets, as modification of these exposed domains, particularly V3, could potentially 
stabilize the unliganded trimer, thereby decreasing infectivity.190,204 
5.3.3 Viral Attachment and Entry 
As the primary effector of HIV entry, CD4 binding is likely the most thoroughly studied 
step in the HIV infection pathway.  As could be expected, the amino acids directly involved with 
the binding pocket are some of the most conserved, located in C1, C3, and C4 domains.205 Within 
the layered structure discussed previously, the CD4 binding region is located in-between layers 2 
and 3 of the inner domain and the outer domain.  A conformational change in the 3rd layer of the 
inner domain serves as a wedge causing a rotation and displacement of the outer domain of 
gp120.206  The overall movement can be described as a rotation combined with a ‘blossoming’ or 
outward separation of the three gp120 units (Figure 5.10).191,207 This movement is responsible for 
many of the conformational changes in gp120 subunits: the rotation is responsible for the 
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uncovering of the V3 domain by an adjacent V1/V2 domain,200 while the hinged opening has been 
shown to be an important step in decreasing the distance between virion and host cell membranes 
via lateral deformation of CD4 proteins (Figure 5.10f).191  Together, these interactions serve to 
prepare the coreceptor binding site by forming the bridging sheet area,181,208 as well as 
repositioning the V3 loop192 so that it is oriented directly away from the virion particle.  
HIV gp41 is the smaller of the two Env proteins, and has three functional units: the 
previously discussed CD participates in intracellular localization and endocytosis, the membrane 
spanning domain (MSD) serves to anchor the Env protein in the lipid envelope, and the 
extracellular domain (ECD), is responsible for interactions with host cells.  The MSD is composed 
of 25 highly conserved amino acids that anchor the protein into the viral membrane with a single 
alpha-helical domain. Mutations in this sequence have been shown to modulate viral fusion 
efficiency, but specific mechanisms remain unconfirmed.174,209  
While the first two domains remain relatively structurally stable, the third domain 
undergoes multiple, complex, conformational changes throughout the attachment and entry 
processes.  This third domain has been recognized as being crucial to understanding the mechanism 
of entry for HIV, but until recently, only basic primary and secondary structural information was 
known.209 In 2014, x-ray crystallography was able to elucidate the dynamic structure (Figure 
5.11A).178 While the gp120 beta-sandwich structure and N- and C- terminal domains of the gp120 
inner domain have been implicated in gp120-gp41 attachment, Pancera, et al. was able to observe 
the structured four-helix collar present in the ECD that maintains the stable confirmation of these 
two gp120 tails (Figure 5.11B).178,193  In agreement with several previous studies,201,210,211 the 
prefusion state of gp41 is shown to contain two main precursor helices to the N- and C-terminal 
heptad repeats (NHR and CHR, respectively) along with unstructured loops.  Across several 
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Figure 5.10. Model for the conformational change from the unliganded (a, c) to the CD4-bound state (b, d) 
shown as top (a, b) and front (c, d) views. The gp120 core, CD4, V1/V2 and V3 stems are shown in white, 
yellow, red and green colors, respectively. e, Schematic description of the gp41 (blue) and gp120 (red/purple) 
regions of the trimeric spike and the conformational changes that occur upon CD4 binding. The yellow patch 
near the apex marks the location of the CD4 binding site in the unliganded spike and the green patch at the apex 
marks the location of the V3 loop region in the spike after CD4 binding. f, Schematic view of the consequence 
of the CD4-induced conformational changes for viral attachment to the target cell and interaction with 
chemokine receptors (green at top). Colors in (f) have same meaning as in (e). 192 
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piecewise crystal structures comprising intermediate states between pre- and post-fusion states, 
the precursor helices were shown to rapidly form two, long alpha-helices upon release of the four-
helix ‘latch’ that place the fusion peptide (FP) in close proximity with the target cell membrane 
where it can enact its membrane-destabilizing mechanism.178 The structure of this post fusion state 
is that of a coiled-coil, a common motif for Class 1 fusion proteins.  
Upon establishment of the post fusion state, the projected FP domain, which is basic and 
strongly hydrophobic, interacts directly with the plasma membrane of the host cell, as a member 
of the Class 1 fusion proteins that includes other viruses such as coronavirus, influenza virus and 
ebolavirus.178,212,213 Upon integration into the membrane, NHR and CHR regions attempt to 
assume a characteristic six-helix bundled formation.  It has been demonstrated that either one or 
two of the CHR moving to the grooves of the NHR trimer is sufficient for membrane hemi fusion, 
and that the purpose of the final six-mer bundle is stabilization of the pore (Figure 5.12).214,215  The 
details of actual lipid rearrangement during pore formation and viral membrane fusion are still 
unclear.  Demonstration of comparatively high concentrations of phosphoinositides provides one 
potential mechanism for mediating instability in close-proximity lipid bilayers.216 These 
membrane structures, much like cholesterol, maintain membrane fluidity, and allow for point-like 












Figure 5.11. A) HIV-1 Env entry rearrangements with gp120 (top) and gp41 (bottom) rearrangements 
between each conformational state highlighted with orange lines depicting movement of each Cα between 
conformations. Subunit models are shown in grey.  The spring-like release of the NHR and CHR can be 
readily observed. B) gp41 forms a four-helix collar, which wraps around extended N and C termini of gp120. 
Both gp120 (red) and gp41 (rainbow from blue to orange) are depicted in ribbon representation. The location 
of the trimer axis is indicated with a ‘3’ inside a triangle. The viral membrane is at the bottom of the image. 
Zoom insert: the gp41 collar is clasped by the insertion of Met 530gp41 into a tryptophan sandwich and by 




As with any field of cutting-edge 
science, there are current debates on 
particular components of the Env structure 
as described here.  Of particular note at this 
time is the dialogue between the Cryo-EM 
and X-ray Crystallography methods, 
particularly the Sodroski and Subramaniam 
labs, in respect to the unliganded form of 
gp41.  Since 2013 when a 6.5 Å Cryo-EM 
structure was published containing an 
unliganded gp41 form with disorganized 
pre-NHR/CHR precursor helices located in 
its core,195,199 a discussion of the efficacy of the method has unfolded.199,218-220 Conflicting results 
have been presented, suggesting a more ordered pre-NHR/CHR organization, which have also 
been supported by separate Cryo-EM studies.201,210,211 Recent consensus appears to support the 
latter,178,221,222 and so the gp41 structure discussed here is of that variety. It is worth noting that the 
discussion is ongoing, with recent discussion of the usage of disulfide-bond modification to assist 
with structural analysis, and its potentially contaminating effect on the determined ordered 
structures.223 Regardless, the fact that gp41 undergoes some sort of conformational change from a 
more compact structure to the classically appreciated NHR/CHR coiled-coil protrusion post-CD4-
binding is readily apparent from either school of thought.  
Figure 5.12. Top panel: The envelope protein is a trimer 
of heterodimers on the virus surface made up of the 
transmembrane subunit, gp41, embedded in the viral 
membrane and the globular surface subunit, gp120, non-
covalently associated to gp41. Association between 
gp120 and CD4 causes conformational changes in gp120 
that lead to binding to coreceptor. Bottom panel: 
Coreceptor binding triggers further concerted 
conformational changes, including formation of agp41 
extended intermediate, that allow gp41 to initiate mixing 
of the outer bilayer leaflet resulting in formation of the 
hemifusion state. Finally, the inner leaflets mix resulting 
in membrane pore formation and injection of the virus 




While many structural investigations have been completed of various portions of the Env 
spike, there is much still to learn about the dynamics.  While beginning and end-point analyses of 
structures (i.e. unliganded and CD4-bound) can provide a general picture of the complex 
conformational challenges, understanding the time-resolved path from conformation A to 
conformation B is a complex issue that necessitates the use of new tools.  One such recent 
development is the use of Forster resonant energy transfer (FRET) with single-molecule resolution 
to look at the inter-protein distances in real time.  Researchers at Yale and Cornell recently 
demonstrated the transient shifting of Env conformations for the unbound state to the canonically-
described CD4-bound state and back, suggesting the binding action-conformational change 
relationship may not necessarily be as causal as has been assumed thus far.202 
The fact that the Env spike is still an area for such intense scrutiny only serves to emphasize 
both its complexity and importance.  As the sole non-host protein exposed on the HIV virion 
surface, Env serves as the sole target for any traditional antibody-based vaccine or therapy.  As the 
underlying mechanism of Env variation and conformational progression during membrane fusion 
events unfolds, the quest for neutralizing antibodies and vaccine candidates is proceeding in 
tandem, benefiting from each new piece of the puzzle.224,225 The past 30 years have seen a 
remarkable increase in awareness, funding, and international cooperation that have spurred much 
of the work discussed. With an ambitious goal of 90-90-90 by 2020 and 95-95-95 by 2030 (95% 
of infected people who know their status, 95% of people who know their status being placed on 
antiretroviral therapy (ART), and 95% of those on ART maintaining suppressed viral load)226 
progress will likely even accelerate.   
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5.3.5 Implications for Direct HIV Detection 
For the successful direct detection of whole HIV virions, the options for serological 
detection are limited.  The few consensus regions discussed here provide strong indicators of where 
future monoclonal antibody development might have success.  Significant work is ongoing in the 
field of serological recognition of HIV virions due to the extensive research being done into 
vaccine development.  The best chances at high-yield capture of the dilute concentrations required 
for viable viral load measurement rely on broadly neutralizing antibodies bnAbs.  For the 
development of the digital detection platform, I believe the use of a similarly polyclonal antibody 
is well-suited for our applications and current project progress.  As research within the realm of 
bnAbs continues in parallel with our development of the optical and microfluidic platforms, it is 
advisable to continue monitoring literature for consensus on which bnAbs might be 1) most stable 
2) reasonable to acquire, and 3) most likely to operate on compatible sites for sandwich-based 
capture.   
5.4 Single Virus Detection of HIV 
 Based upon previous whole-virion detection in a static setting,82 we selected a high-
selectivity, high-affinity surface functionalization for our polyclonal antibody immobilization.  
After cleaning the gridded PC surface discussed in 5.3, overnight chemical vapor deposition 
(CVD) of (3-Mercaptopropyl) trimethoxysilane (3MPTS) results in a SAM of sulfhydryl groups.  
To minimize linear distance between detectable nanoparticles and the PC sensor, a maleimide-
activated Neutravidin was used in combination with a biotinylated anti-gp120 antibody (Abcam).  
Nanoparticles were attached to anti-gp120 via the same SH-PEG chemistry used in Section 5.1. 
The overall detection scheme can be seen in Figure 5.13.   
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As can be seen in Figure 5.14, we were able to observe both HIV and nanoparticles on the 
sensor surface.  HIV itself does not appear to generate a measurable signal via either PIV or PWV 
images from the PCEM; however, the nanoparticles generate a clearly-visible signal.  By using the 
previously described grid, corresponding areas of the PC sensor were imaged by both PCEM and 
Figure 5.13. Schematic of HIV Direct Detection. 3-MTS serves to thiolate the surface of the PC sensor, 
which forms high-affinity bonds with the maleimide-activated Neutravidin.  A biotinylated anti-gp120 
antibody serves as the final functional layer.  All components are drawn approximately to scale. 
Figure 5.14. A. SEM image of magnetic nanoparticles, comprised of gold core and nickel decorations.  B. SEM 
of HIV virion. 
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SEM, and SEM images were analyzed for potential HIV virion-nanoparticle complexes.  One such 
complex can be seen in Figure 5.15.   
 Having located a complex of interest in a gridded section that had been scanned via PCEM, 
spatial locations were aligned (as described in Section 5.2) and an overlay was used to identify the 
respective location in the PCEM scan.  In panel A, the grid pattern can be observed across the top 
and right side of the full PIV image.  B shows a composite image resulting from the overlay of 
SEM and PCEM images, and shows clear PIV shifts for many of the nanoparticles observable in 
the SEM image.  Panel D has a series of bright yellow regions in a line, indicating substantial 
decreases in PIV.  These are resultant from a series of deformations in the periodic structure of the 
grating, and they help to orient the reader to the alignment between the images.  In panel E, 
representative spectra from within the region of interest and just outside are shown, demonstrating 
a clear decrease in PIV, and a slight positive shift in PWV, as expected.  A close-up view of the 
HIV-nanoparticle complex is shown in panel F.   
5.4.1 Improvements for Collection Efficiency 
 As discussed in previously in this Chapter, one of the most substantial challenges in 
developing a viable POCT assay for HIV viral load is balancing the time-dependence of the 
diffusion of virions to the sensor surface with a reasonable measurement duration for the POC 
testing paradigm.  A principal way in which we can overcome this time constraint is by mixing the 
HIV sample with functionalized antibodies prior to introduction to the PC sensor.  This allows for 
the HIV-NP binding event to take place in 3D space, leaving a single 1D diffusion step (as opposed 
to the two serial 1D diffusion steps required if HIV sample and NP solution are flowed over the 





Figure 5.15. Validation of PC-captured HIV-Nanoparticle Complex.   A. C., Normalized PIV images from PCEM showing the location of many nanoparticles, 
and a single HIV-nanoparticle complex.  B. Composite image of C & D with 50% transparency to observe colocalization of PIV features and observed SEM 
nanoparticles.  The red box shows the location of the detected HIV-nanoparticle complex.  F. Peaks of representative pixels from inside and outside the complex 
area showing shifts in PWV and PIV.  Solid lines represent cubic curvefit used to calculate PIV and PWV.
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 To that end, we can further accelerate the process by incorporating a complimentary 
technology being developed by our collaborators in the Singamaneni lab at Washington University 
in St. Louis.  By decorating octahedral gold nanoparticle cores with nickel, resonant-wavelength-
tuned particles can be created that also exhibit ferromagnetic properties.  Thus, by performing 
incubation of a mixed HIV-sample/conjugated NP solution on a PC sensor with a bar magnet 
located underneath (visible in Figure 5.16C), the magnetic field can bias diffusion toward the 
sensor for the rate-limiting 1D diffusion step.  
5.4.2 Microfluidic Design 
 While COMSOL simulations were crucial for developing an intuition for how channel 
dimensions affect the flow rate and size/shape of the depletion region over the PC sensor, practical 
experimentation was an important component of designing our prototype microfluidic device.  
Knowing we wanted to rely on a passive “pump” to drive the microfluidic flow, it was necessary 
to run a series of experiments on types, thicknesses, sizes and shapes of filter paper pads.  The two 
criteria used to assess the filter paper capillary pumps were capacity (it must hold 200 µL of liquid) 
Figure 5.16. Design of the Microfluidic Chip. A. Alternating layers of laser-cut acrylic sheet and double-sided 
adhesive provide the structure of the chip which contains a detection chamber, where the PC is located, a 
serpentine channel to provide some flow resistance, and a multi-layer sandwich of filter paper to provide our 
passive capillary action pump.  B. One of the microfluidic chips used to experimentally determine filter paper 
pump dimensions to pump 200 µL in 30 minutes.  C. PC sensor incubating on top of a magnet. D. Epoxy used to 
remove PC sensor from microfluidic device.  E. Removed PC sensor. F. PC sensor prepped for SEM showing 
clear fragmentation of the sensor surface from the removal process.  
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and flow rate (it should take between 30 and 45 minutes for a 200 µL of liquid to flow through the 
sensing region.   The resultant sensor design is based on a multi-layer lamination of layers 
comprised of acrylic sheet, double-sided adhesive (DSA), and filter paper (Figure 5.16A).  An 
inlet chamber (capable of holding up to 100 µL of liquid) is connected to the PC sensing region 
by a 1-mm-wide channel which continues on the other side of the PC sensing area.  Next, the liquid 
is introduced to a short serpentine channel, followed by its exit onto the laminated filer paper.   
 Two full microfluidic experiments have been completed thus far, though SEM validation 
with the microfluidic platform is more challenging.  As the PCs are fabricated on cover glass, 
detaching them from the DSA interface with the microfluidic chip resulted in the first several 
sensors shattering.  A new method of curing quick-set epoxy on the underside of the PC has been 
developed to allow for removing the PC from the chip.  Even with this method, which does largely 
preserve the glass cover slip, albeit in many smaller pieces, the UVCP appears to be bound to the 
PC itself less strongly than the DSA applied during microfluidic chip fabrication.  A second epoxy-
curing on the underside of the thin UVCP/PC film has allowed for SEM mounting and imaging.  
Due to the significant increase in difficulty of obtaining SEM images, validation of the 
microfluidic improvements to the binding dynamics of the device are likely best completed by 
scanning multiple areas of the PC for known (and verified) concentrations of virus.   
5.5 Toward a Point-of-Care PCEM Instrument 
 From the work thus far, direct detection of HIV via PCEM continues to demonstrate 
significant promise.  But that’s not to say that issues haven’t arisen along the way.  A few of these 
I would like to elaborate on possible ways to address them, in particular, as we design a portable 
PCEM instrument to build upon the work completed thus far.  
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 As soon as we completed our first SEM validation of nanoparticles detected via PCEM, I 
first noticed a pattern among nanoparticles that provided sharp, clear PIV responses and those that 
provided essentially none.  In Figure 5.3, there are approximately 10 nanoparticles that do not elicit 
a localized decrease in PIV.  At the time, I recognized that all of these ten nanoparticles appeared 
on the “top” surfaces of the PC device.  In going back and looking more closely, in addition to all 
“undetected” nanoparticles appearing on the PC plateaus, all of the tens of detected nanoparticles 
exist in or adjacent to the troughs in between.  This is not the first time we’ve thought about 
location-specific implications for nanoparticles.  In our 2014 paper first describing single 
nanoparticle detection on the PCEM, simulations were run for both dielectric and metallic particles 
of TiO2 and Au, respectively.  In figure 2, 100nm nanoparticles (the precise size used in this work) 
are modeled to show FDTD E-field distribution.  It looks as if there is about a 50% theoretical loss 
of PIV shift between the two modeled locations.  While that doesn’t completely explain the 
absence of particles, it does suggest that further investigation of how the PC structure responds to 
attachment events at different locations in its period.  In addition to landing on different parts of 
the surface, the direct HIV detection discussed in this work relies on two binding events, which 
further increases the locational variation of nanoparticles that we would hope to register on our 
point-of-care device.   
 Another concern is most certainly the extent to which losses of capture efficiency 
compound upon each other.  With very low numbers of analyte that we are hoping to enumerate, 
each “missed’ particle has substantial consequences.  With both known losses (inability to have 
100% of the sample have enough residence time to bind to the sensor surface), and unknown losses 
(Env viral shedding? Conformational changes?) there remains significant amounts of risk for the 
limits of detection that may be possible.  Something worth investigating further might be the 
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possibility of using a viral protein target with more copies per virion.  Copies of both p17 (matrix 
protein) and p24 (capsid protein) are in the hundreds/virion range, which would increase the 
number of potential analytes in a patient sample from the 1-10 range to the 1000-10,000 rage, 
which in turn, would result in a more robust device capable of tolerating more errors as a result of 
“lossy” biology.   
 Finally, as for the actual design and construction of the portable PCEM instrument, I firmly 
believe in minimizing moving parts, and the value of rapid-prototyping.  The rate at which the 
development of the first-generation smartphone spectrometer (machined aluminum) and second-
generation (3D printed in-house) could take place were so incredibly different.  The ability to 
affordably and quickly test out components, or even build custom optical mounts, made a world 
of difference.  Furthermore, the collective body of experience in lab presents a natural advantage 
to working with other prototyping systems.  The work thus far on the POC PCEM platform for 
viral load monitoring has been incredibly promising, and I look forward to continuing to work 




CHAPTER 6: CONCLUSIONS 
In the first half of this dissertation, I have presented the evolution of smartphone-based 
spectroscopic biosensing.  The work in Chapter 2, when published, represented the first 
demonstration of a smartphone camera for spectrometric measurement of biological samples, and 
set off a significant amount of interest in the area both within the academic community and the 
public.  From that initial demonstration, we have traced the development of a smartphone-based 
spectrometer into a truly handheld, 3D printed prototype capable of performing the most common 
spectroscopic assays commercially available with comparable limits of detection. While there are 
still a few interesting research questions remaining related to the developed TRI-Analyzer, 
including the possibility of performing scattering-based measurements, I am excited for the project 
to graduate to the realm of commercialization.   
 In the second half of this work, I presented the evolution of Photonic Crystal Enhanced 
Microscopy from a micro-scale attachment sensing platform to a nano-scale binding-event 
detector.  The work in Chapter 4 touches on just a few of the myriad of cellular-based assays that 
could be investigated, with particular future potential in the areas of stem-cell differentiation, drug 
screening, and even personalized medicine.  For the point-of-care, though the PCEM platform hold 
enormous promise as a mechanistically-simple, spatially-resolved platform capable of discerning 
individual binding events.  The discussed benefits for diagnostics for infectious pathogens, 
including HIV viral load, make the PCEM ideally suited for further development in situations with 
extremely low numbers of expected analyte.  In Chapter 5, I present the body of work that has 
already been put forward toward the goal of a portable PCEM instrument developed specifically 
to perform point-of-care viral load monitoring.   
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From my exposures to the many parts of the diagnostic design process, from the generation 
of new ideas through the selection and performance of proof-of-use assays, I have been able to 
observe the development of the field of smartphone biosensing as a whole.  The number of 
researchers has increased dramatically in this area, and I believe will continue to expand, which in 
turn, will push smartphone based biosensing toward the frontiers of research, where perhaps they 
will continue to provide interesting diagnostic platforms to users and researchers alike as the lines 
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